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Gonorrhea, a common sexually transmitted infection, is caused by the gram-
negative bacterium Neisseria gonorrhoeae. In the female reproductive tract, gonococci 
(GC) initiate infection at the apical surface of columnar endocervical epithelial cells. 
These cells provide a physical barrier against mucosal pathogens by forming continuous 
apical junctional complexes between neighboring cells. This study examines the 
interaction of GC with polarized epithelial cells. We show that viable, but not gentamicin 
killed, GC preferentially localize at the apical side of the cell-cell junction in polarized 
endometrial and colonic epithelial cells, HEC-1-B and T84, respectively. In GC infected 
epithelial cells, continuous apical junctional complexes are disrupted, and the junction-
associated protein β-catenin is redistributed from the apical junction to the cytoplasm and 
to GC adherent sites. However, GC inoculation does not change the overall cellular level 
of junctional proteins. This redistribution of junctional proteins is associated with a 
  
decrease in the apical junction’s barrier function against the lateral movement between 
the apical and basolateral membranes, but not against the permeability through the 
paracellular space. Disruption of the apical junction by removing calcium increases GC 
transmigration across the epithelial monolayer. GC inoculation induces the 
phosphorylation of both epidermal growth factor receptor (EGFR) and β-catenin, while 
inhibition of EGFR kinase significantly reduces both GC-induced β-catenin redistribution 
and GC transmigration. These results suggest a relationship between junction protein 
redistribution from the plasma membrane with the resultant weakening of the junctional 
complex, and an increase in the ability of GC to transmigrate. The presence of the female 
sex hormones estrogen and progesterone, lead to an increased degree of disruption of the 
junctional complex and enhance GC transmigration across the monolayer. Therefore, GC 
are capable of weakening the apical junction and the polarity of epithelial cells via 
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Chapter 1: Introduction 
1.1 Disease of gonorrhea 
Sexually transmitted infections (STIs) are a leading cause of diminished healthy 
living, especially of young women in developing countries. Not only can they lead to 
serious and sometimes fatal complications, but they also facilitate the increased 
transmigration of human immunodeficiency virus (HIV) [1, 2]. Gonorrhea is a STI that 
has been recorded as early as the 18th century. Initially gonorrhea and syphilis were 
considered the same infection. It was not until 1838 that they were accepted as separate 
diseases and in 1879 Albert Neisser described the morphological characteristics of the 
bacteria later identified as the causative agent of gonorrhea [3].  
Neisseria gonorrhoeae (GC), a gram-negative bacillus, is an obligate human 
pathogen. GC generally affects the mucosal epithelia in the urethra in males and the 
uterine cervix in females. However, it can also infect the rectum, throat (from sexual 
activity) and eye (from the birth canal) [4]. Complications arising from infection in males 
are relatively uncommon, as the infection is readily recognized and cleared by the 
immune system. However, in females approximately 50% of the infections are 
asymptomatic, and complications can develop from the infections. The most common 
complication is pelvic inflammatory disease (PID), and approximately 40% of PID cases 
are associated with a gonococcal infection [5]. Of these 10-15% may lead to infertility as 
a result of the scarring of the reproductive tract and/or blockage of the fallopian tube [6]. 
Other syndromes caused by GC include endocervicitis, urethritis, epididymitis, proctitis, 




expansive, ranging from a complete lack of symptoms, to apparently insignificant 
symptoms that can be misdiagnosed as a non-consequential infection to significant and 
visible symptoms. 
  While the urethra is the predominant site of all infections in males, in women it is 
generally the site of symptomatic infections. The female urethra is lined by stratified 
squamous epithelium with a few areas of columnar epithelium, while the male urethra 
consists almost exclusively of columnar epithelium, both stratified or pseudo-stratified. 
GC preferentially infect non-ciliated columnar epithelia, thus making the male urethra an 
ideal site for primary gonococcal infection [7]. Depending on the location of the infection 
within the female reproductive tract (FRT), the infection progression can vary. GC 
infection through the endometrium can lead to a range of manifestations, from an 
uncomplicated generally asymptomatic infection to a complicated PID situation [8]. The 
clinical manifestations of gonorrhea in women include cervicitis (abnormal vaginal 
discharge), urethritis (painful urination and frequency of urination), acute bartholinitis 
(labial pain or swelling) or abnormal uterine bleeding and/or lower abdominal pain. Some 
of these symptoms strongly resemble the clinical presentations of urinary tract infections 
(UTIs) and as such are ignored or improperly diagnosed [1]. PID has a collection of 
symptoms, which include, acute endometritis, salpingitis and peritonitis and is caused by 
dissemination of GC from the cervix to the upper tract of the female reproductive system 
[3]. The rate of PID in women with a GC infection has increased from 20% in the 1980’s 
[3] to 30-40% in the early 2000s [5]. The dissemination of GC infection beyond the 
reproductive tract can lead to disseminated gonococcal infection (DGI), which can 




Antibiotics are the most effective treatment for gonorrhea. One of the earliest 
treatments was prontosil, a sulfonamide that was introduced in 1935. Penicillin was used 
when over 25% of patients no longer responded to prontosil. However, by 1955 there 
were reported cases of gonococcal penicillin resistance [10, 11]. After these reports 
tetracycline, chloramphenicol, streptomycin and spectinomycin were all tried [3]. The 
current recommended treatments include cefixime, ceftriaxone or cephalosporin. There 
was an increase in GC resistance to antibiotic treatment observed in 2010 to all 
antibiotics, suggesting the possibility of a developing superbug [6] and by extension a 
health crisis, since the current line of treatment is the last line of defense available. Due to 
a high level of coinfection with Chlamydia, gonococcal treatments sometimes include 
regimens that are also effective against uncomplicated chlamydia e.g. azithromycin or 
doxycycline [6, 12].  
 
1.2 Pathogenesis of Neisseria gonorrhoeae 
GC pathogenesis has been extensively studied in non-polarized epithelial cell 
culture in vitro, and a general consensus has been attained on the basics of the process. 
Within the first hours of infection GC appear to preferentially attach to the microvilli of 
non-ciliated columnar epithelial cells, where the microvilli are observed not only in 
contact with the GC, but also surrounding them. This initial attachment appears to be 
mediated by the GC type IV pili [13]. Pili are filamentous polymers that are 
approximately 6 nm in diameter and can be several microns in length. These fibers are 
not only involved in attachment, but also in GC aggregation and twitching motility, 




the first recognized receptor of pili and is found on epithelial, endothelial and sperm cells 
[4, 15]. Based on its significant role in GC adherence to host cells, variations of pili 
factors have been shown to have a significant effect on GC pathogenicity [4].  
After initial attachment, host cell lamellipodia and ruffles are observed at the site 
of GC adherence [8]. GC then become intimately attached to the host membrane [4, 16, 
17]. Opacity protein (Opa, or protein II) plays a role in strengthening the interactions 
between the GC and the host cells as well as interactions within the gonococcal 
microcolonies [3]. Due to the numerous variants of Opa that are present within a given 
microcolony, the effect of one specific Opa variant is difficult to elucidate, even though it 
is known that different expressed Opas have differing effects on GC-host interactions and 
overall pathogenesis [18]. Opa proteins can bind to numerous receptors on the host cells, 
including heparan sulfate proteoglycans (HSPGs) that facilitate the recruitment of F actin 
and tyrosine phosphorylated proteins to the site of attachment [19], and CD66 that can 
lead to GC uptake and activation of signaling cascades [20-22].     
Lipooligosaccharide (LOS) is another GC surface component involved in 
pathogenesis. GC interacts with host surface receptors such as asialoglycoprotein 
receptor [23-25] and triggering receptor expressed on myeloid cells-2 (TREM-2) [26] via 
LOS. The presence of LOS also allows GC strains lacking Opa to still invade into host 
cells and this invasion is enhanced by the presence of the lacto-N-neotetrose [27].  
GC are then engulfed by the host cells [4], where they are observed to be both 
cytoplasmic and within vacuoles [17, 28, 29]. Though piliated GC adhere better to host 
cells, there is no observable difference between the efficiency of internalization of 




was observed by Timmermann et al. that after inoculation for the same amount of time, 
approximately 20 fold more GC adhered to endometrial cells than invaded them [8]. The 
mechanism of internalization appears to require the actin cytoskeleton, since treatment 
with the actin polymerization inhibitor cytochalasin D inhibited GC internalization. It 
was observed by Shaw et al that while N gonorrhoeae MS11 and F62 (pathogenic 
strains) readily invaded into host epithelial cells, N lactamica (commensal strain) did not 
significantly invade even after 12 h of incubation [28].  
Once internalized from the apical (top) surface of the cell, the bacteria multiply 
within and traverse to the basal (bottom) membrane. In non-polarized cells and organ 
culture, transcytosis across the monolayer occur over a 24-48 h period [16, 17, 28]. 
Vacuoles containing GC are seen to fuse with the basal membrane and the bacteria are 
released into the underlying layer. These bacteria can then attach to and invade these 
deeper epithelial layers [17]. In addition to its role in invasion, LOS also binds to and 
activates dendritic cells via the SIGN (CD209) receptor [30]. GC variation of its LOS 
sequence can lead to changes in cytokine production [31] and be used as a mechanism to 
evade the host immune response [30, 32]. This extensively studied pathogenicity pathway 
of GC in non-polarized cells is shown in Fig. 1.  
Analysis of GC pathogenesis in polarized cells has not been as extensively 
analyzed. However, from the work that has been performed transmigration of GC across 
a polarized monolayer was shown to occur as early as 10 h post inoculation [33], with a 
mid-range of 24 h [34] and as late as 36-48 h [35].  A comparison of transmigration (total 
number of bacteria that cross from the apical to basal side), versus traversal (bacteria that 
























Figure 1. Steps in gonococcal infection.  This model shows the epithelial cells 
apically inoculated with GC. Bacteria initially attach using pili, intimate attachment 
occurs via Opa and/or LOS interaction with host surface receptors. Bacteria are then 




transmigration assays [34]. This suggests that GC might cross the monolayer by 
mechanisms additional to invasion/exocytosis. Both pili [35] and the presence of fit genes 
[33] appear to enhance GC transmigration. Similar to invasion, the actin cytoskeleton is 
also involved in GC transmigration as actin inhibitors reduce the ability of GC to 
transmigrate [34]. The integrity of the monolayer, as observed by transepithelial readings 
and permeability to dyes, was not affected by the passage of GC [34, 35]. Due to 
experimental difficulties and differences between the numerous GC strains and variants 
used, a consensus has not been attained with regards to the mechanism(s) used by GC for 
transmigration. 
GC is a phase and antigenic variable organism, with the majority of its surface 
proteins capable of varying at a high frequency. The definition of phase variation is that 
the gene expression is controlled by an on versus off switch, while antigenic variation 
means that the primary sequence of a protein is being changed. Phase and antigenic 
variation is observed in many bacteria and even in pathogenic viruses and parasites. This 
constant changing of the surface molecules confers on GC a survival advantage by 
facilitating evasion of the immune system and must be considered a significant feature of 
GC infection [4]. Gonococcal surface molecules, Pili (P+), Opa (O+) and LOS, have been 
shown to play essential roles in pathogenesis, and phase vary at ~104 [36], ~103 [37] and 
~104 [38] respectively. The variability of the surface molecules also affects GC-GC 
interactions, consequently changing the morphology of the bacterial microcolonies. 
Based on colony morphology and surface expression, Kelloggs originally designated GC 
as T1 (P+O-), T2 (P+O+), T3 (P-O+) and T4 (P-O-). These classifications were established 




Variation of Opa occurs due to the presence of a repetitive coding repeat (CR) 
sequence. The number of repeats that are present determines whether the reading frame 
for a specific Opa is in or out of frame and therefore whether the protein is translated 
[37]. CR sequences are independent for each Opa gene and thus autonomous of each 
other [40]. Pilin variation is due to the homologous recombination event between several 
silent gene copies (pilS) and the expressed pilin gene (pilE) [41, 42]. Production of 
truncated S-pilin, which is secreted instead of polymerized into the pilin, can occur [43]. 
LOS also undergoes variation. There are poly-G tracts found within the coding frames 
responsible for glycosyl transferase. Slippage of these tracts can cause termination of 
transferase translation and thus LOS structure [44].  
 
1.3 Epithelial cells and the junctional complex 
Initially it was believed that the barrier formed between polarized cells was 
simply a thickening of the intracellular areas involved in the contact, and this unregulated 
seal was termed the ‘terminal bar’. Using electron microscopy (EM), it was found that 
there are actually several independent and distinct junctions that function together, and 
these were later named the tight junction (TJ), adherens junction (AJ), desmosome and 
gap junction [45, 46]. The most apically localized of these junctions is the TJ. The TJ and 
the AJ together form the apical junction (Fig. 2). The apical junction has two functions: 
to create a diffusion barrier to small solutes and to separate and maintain proteins and 
lipids in their correct apical or basolateral location in the cell membrane [45, 47, 48]. 
Different imaging techniques illustrate different characteristics of the TJ. Under 



























Figure 2. Location of the apical junctional complex.  This modified figure 
shows the location and proteins that comprise the Tight junction (TJ) and 





fracture electron microscopy show rows of molecular particles that form a continuous 
branching network of parallel and interconnected strands, localized at the contacts 
between apposing cells [45, 46, 49]. It has been theorized that the density of these 
networks directly affects the functionality of the TJ, since the denser the network, the 
greater the transepithelial electrical resistance (TER) and the less paracellular solute 
permeability observed [50]. The strength of the TJ barrier varies depending on the types 
of epithelium and generally relates to the physiological function of the epithelium. If 
there is a low level of permeability and a high TER, then the junction is considered 
‘tight’, while if the permeability is high and TER is low, the junction is considered 
‘leaky’ [45, 47]. Electron microscopy analysis of the AJ shows parallel apposing 
membranes with an intercellular space that consists of numerous cylinder-like 
appendages. Additionally, the cytoplasmic region of the AJ consists of a plaque of 
proteins and actin filaments [51].  
The TJ consists of transmembrane and cytoplasmic proteins. The transmembrane 
proteins, including occludin, claudin and junction adhesion molecules (JAMs) are 
assembled together and associate with the actin cytoskeleton via the cytoplasmic zona 
occludin (ZO) proteins [46, 52]. It has been demonstrated that occludin is involved in 
cell-cell adhesion and the permeability barrier. Even though occludin appears to be a 
consistent component of all TJs, sequence comparison across various species shows a 
surprisingly high divergence in the amino sequence [45]. This 65 kDa protein has four 
transmembrane domains, two extracellular loops involved in TJ function and cell-cell 
adhesion and the cytoplasmic amino (N) and carboxy (C) tails. Extracellular loops of 




paracellular seal [45, 46, 53]. McCarty et al and Balda et al demonstrated the function of 
occludin by transfecting occludin into cells. This led to an increase in the number of 
occludin fibers and TER of the cells [53, 54]. There are multiple isoforms of occludin, 
providing an explanation for the diversity of paracellular permeability among various 
types of epithelia [52]. While the C terminus is not required for the barrier function, the 
last ~150 amino acids of the C terminus are required for occludin’s localization at the TJ 
[46]. Phosphorylation of occludin regulates its functionality. Occludin in polarized cells 
is phosphorylated at its serine (Ser) and threonine (Thr) residues with much lower levels 
of tyrosine (Tyr) phosphorylation. Upon disruption of the junctional complex, there is a 
decrease in Ser/Thr phosphorylation, but an increase in phosphorylation of the Y398 and 
Y402 residues in the C terminal domain [53].   
ZO-1 is the most studied TJ protein. This 220 kDa phosphorylated protein is 
found in all cells, while the 160 kDa ZO-2 is found only in cells that have formed tight 
junctions. These two proteins are members of the membrane-associated guanylate kinase 
(MAGUK) protein family. The MAGUK family consists of proteins that are associated 
with the plasma membrane at regions involved in cell-cell contact, and likely provide 
scaffolds for organizing TJ transmembrane complexes. This most likely results due to the 
presence of multiple protein-protein interaction domains [45, 55]. ZOs have multiple 
PDZ domains that interact with the hydrophobic motifs of their target proteins. Each also 
contains a Src-homology (SH) 3 domain that mediates protein-protein interactions by 
binding to proline rich domains (PRD). The ZOs also have a region that shares homology  

















































Figure 3. Interaction of junctional proteins and actin with ZO domains.  ZO 
proteins function as scaffolding proteins, linking the junctional complex proteins 
to the actin cytoskeleton. Modified from Bauer et al (2010). Jour of Biomedicine 




ZOs are also involved in organizing and facilitating signal transduction. ZO-1 binds 
occludin via its GUK region, while binding claudin and JAM via the PDZ domain (Fig. 
3). Essentially ZO binds these proteins via its N terminus and the actin cytoskeleton via 
its C terminus. This links the TJ to the actin cytoskeleton and facilitates the assembly of 
the junction. Junction-associated actin and its motor myosin, which form a supporting 
ring around the apical junction, can exert a contraction force on TJs, causing junctional 
proteins on apposing cells to move away from each other. This can lead to weakening of 
the junctional complex and increase permeability via the paracellular space [46].  
  The adherens junction (AJ) is localized immediately beneath the TJ. Differing 
from TJs there is a visible space between the membranes of opposing cells when 
observed under an electron microscope. Similar to the TJ, the AJ links the membrane and 
cytoskeleton at sites of cell-cell contact [46, 51]. The formation of the AJ has been shown 
to be required for the assembly of the TJ, and the stability of the AJ is important for the 
continued maintenance and functionality of the TJ. The major components of the AJ are 
members of the cadherin super family. This family of proteins can be divided into six sub 
families: classical cadherins type I (E, N, P, R-cadherins); classical cadherins type II 
(cadherin-6 to 12); desmosome cadherins (desmocollins, desmogleins); cadherins with a 
very short or no cytoplasmic tail; protocadherin and distinctly related products [56]. In 
epithelial cells the major functional cadherin member is a classical Type I, E-cadherin. It 
is a 120 kDa, single pass transmembrane glycoprotein that mediates intercellular 
adhesion in a Ca2+ dependent manner [46, 51]. E-cadherin has 5 ectodomains (EC1-5) 
that bind to Ca2+ and mediate trans-homophillic interactions between E-cadherin on 




cytoskeleton and cytoplasmic signaling molecules including catenins and α-actinin. E-
cadherin binds to the armadillo sequence repeats of β-catenin, and this interaction is 
required for the transport of newly synthesized E-cadherin to the plasma membrane [46].  
β-catenin is a member of the catenin family which consists of alpha, beta and 
gamma catenin. It is a 90 kDa protein that consists of 13 repeats of a 42 aa armadillo 
sequence. It also has a highly conserved serine (Ser) rich region. The phosphorylation of 
three conserved serines increases its affinity for E-cadherin. In contrast, the 
phosphorylation of tyrosine at positions 489 and 654 disrupts its interaction with E-
cadherin [51, 56, 57]. It has been shown that the Tyr phosphorylation of β-catenin by 
pp60c-src led to a 5-fold decrease in its ability to bind to E-cadherin and mutation of 
Tyr654 to phenylalanine (Phe) negated this decrease [58]. This makes β-catenin a central 
component of the AJ architecture [56]. The final armadillo repeat forms a long helix with 
a positively charged grove that accommodates the cytoplasmic tail of E-cadherin and 
binds via ionic interactions [58]. The interaction between E-cadherin and β-catenin 
appears to be the rate-limiting step to the establishment of the junctional complex [46]. 
Additionally, the interaction between E-cadherin and β-catenin has a protective effect 
against the proteolysis of E-cadherin [51].  
In epithelial cells, E-cadherin, β-catenin, α-catenin and ZO-1 first assemble at the 
junctional complex, followed by recruitment of occludin and claudin [59]. Disassembly 
of both the TJ and AJ is caused by directly modifying components of both junctions, or 
by indirect effects mediated via the cytoskeleton. Detectable signs of the disassembly of 
the junctional complex include decreased TER, increased permeability of molecules, 




catenin from the AJ [60-62]. Disassembly can occur by three main methods. Firstly there 
is signaling that leads to movement of junctional proteins away from the junctional 
complex. Increased phosphorylation of both ZO-1 and β-catenin is responsible for the 
redistribution of these proteins away from the junctional complex. The phosphorylation 
of β-catenin prevents it from binding to E-cadherin, and this essentially disrupts the 
foundation of the junctional complex. Additionally, disruption of the E-cadherin-β-
catenin interaction disconnects the link between the AJ and the actin cytoskeleton, 
thereby further affecting the overall stability of the junctional complex [46]. 
Phosphorylation of β-catenin also activates its transcriptional activity and appears to 
cause downregulation of ZO-1[63]. However, since the half-life of these proteins range 
from 6-12 h, regulation at the transcription level cannot account for the observed rapid 
disassembly of the junction [46].  
Secondly there is endocytosis of the junctional proteins. Intracellular 
accumulation of both ZO-1 [64, 65] and cadherin [66, 67] has been reported, providing 
evidence for this mechanism. Additionally, proteins known to be involved in endocytosis, 
such as Rab13, VAP33 and Sec6/8 have been shown to regulate the assembly of the 
junctional complex [68-70]. Various pathogens, either directly or indirectly cause 
increased internalization of both TJ and AJ proteins [71]. There can be constitutive low-
level internalization of proteins such as E-cadherin and occludin, which are continuously 
shuttling between the junctional complex and endosomes [72-74]. Selective 
internalization of TJ proteins as seen in intestinal epithelial cells exposed to E.coli 
cytotoxic necrotizing factor-1 or IFNγ [75] can also occur. Previous studies have shown 




macropinocytosis, are involved in junctional complex internalization. It has been 
proposed that different endocytosis pathways internalize junctional proteins at different 
rates, target them to different subcellular compartments and thus cause different levels of 
junctional disruption [71].  
Finally, there can be complete internalization of both TJ and AJ proteins as seen 
when cells are depleted of Ca2+ [76, 77]. A chemical means of disrupting the junctional 
complex is provided by the addition of the Ca2+ chelator, EGTA. In the absence of 
EGTA, the TJ proteins (ZO-1, occludin, claudin) appeared exclusively at the membrane 
as a continuous network, while a small amount of AJ proteins (E-cadherin, β-catenin) 
were localized in the cytoplasm. After EGTA treatment there was diffuse localization of 
ZO and occludin at the junction, while E-cadherin and β-catenin were observed 
throughout the cell. Removal of EGTA led to complete and rapid reassembly of the 
junction proteins [78].  
 
1.4 EGFR 
The function of the TJ and AJ can be regulated by external or internal signals 
transmitted through cellular signaling pathways. A major manipulation is 
phosphorylation of junctional proteins. In epithelial cells, ErbB receptors are key surface 
receptors that control cell survival and replication. A link between activation of the ErbB 
family of receptors and junction disruption has been established in carcinomas [79].  
The ErbB family consists of four members, EGFR/ErbB1/HER1; 
ErbB2/Neu/HER2; ErbB3/HER3; ErbB4/HER4. They contain an extracellular domain 




cytoplasmic domain that contains a tyrosine kinase domain and multiple phosphorylation 
sites. Ligand binding induces the formation of receptor homo and heterodimers, which 
leads to the activation of the tyrosine kinases and trans-autophosphorylation of tyrosines 
in the cytoplasmic tail. ErbB2 does not bind to ligand and cannot form homodimers, but 
it is capable of forming heterodimers with other family members. ErbB3 is only 
functional when it forms a heterodimer [79]. Downstream signaling molecules bind to the 
phosphorylated tyrosines in the cytoplasmic tail of the receptors (Fig. 4). Many signaling 
molecules bind to these receptors and each binds to specific sites on particular family 
members. This in turn initiates specific and conserved signaling cascades [80]. 
Ligands that bind to the ErbB family of receptors are loosely grouped into three 
(3) groups: First, those that bind specifically to ErbB1/EGFR including epithelial growth 
factor (EGF) and tumor necrosis factor alpha (TNFα), second, those that bind to both 
ErbB1 and ErbB4 including heparin binding EGF (HB-EGF) and epiregulin (EPR) and 
finally neuregulins (NRGs) with NRG1 and 2 binding to ErbB3 and B4, and NRG 3 and 
4 binding to ErbB4 [79].     
ErbB1/EGFR is the most studied member of this family of receptors. EGFR can 
bind to its ligands with two different affinities, however, low-affinity binding constitutes 
approximately 90% of all binding [81]. There are six tyrosine residues that can be auto-
phosphorylated and four that can be phosphorylated by src kinases. The specific residue 
that is phosphorylated depends on the ligand present, ligand concentration and 
dimerization partner. The major cytoplasmic proteins that bind to phosphorylated EGFR 




























Figure 4. EGFR phosphorylates numerous cytoplasmic proteins.  When 
the EGFR receptor dimerizes its kinase activity is activated and many 
cytoplasmic proteins are tyrosine phosphorylated. The cytoplasmic proteins 
interact with tyrosine molecules at specific positions so different pathways 
are activated based on which tyrosine molecule is involved. Modified from 
http://www.biomol.de/wiki/index.php=EGFR_Pathway_Map.  
EGFR Stimulation 
(EGF, TGF-α, etc)          
 Homodimerization and  
 Autophosphorylation             




the signaling pathway that is activated. Binding of Grb2 and/or Grb2/Shc leads to 
activation of the MAPK and phospho inositide 3 kinase (PI3K) pathways. Binding of 
PLCγ leads to cleavage of phosphoinositol 4,5 bisphosphate (PIP2) and the resultant 
activation of protein kinase C (PKC) [82]. Interaction with Gab1 induces activation of 
phosphoinositol 3,4,5 triphosphate (PIP3) and the downstream activation of the AKT 
pathway [83]. These cascades lead to numerous outcomes including cell proliferation and 
differentiation, cell metastasis, apoptosis suppression and calcium modulation [80]. 
Different binding affinities also lead to activation of different signaling cascades, with 
low-affinity binding apparently being the preferential binding for activation of 
intracellular signaling including Ras/MAPK and P13K/Akt signaling pathways [84].  
EGFR is predominantly expressed at the basolateral surface of polarized epithelial 
cells [85], but functional EGFR receptors have been detected on the apical surface of 
epithelial monolayers [86]. Proteins such as Erk show no difference in Tyr 
phosphorylation when basally or apically located EGF receptors are activated [86, 87]. 
Ligand binding also induces EGFR internalization as a signaling down-regulation 
mechanism [88]. It appears that internalization of EGFR is more efficient on the 
basolateral side, which coincides with the observation that there is more efficient down 
regulation of basolateral EGFR [87]. Basal exposure of EGFR ligands causes transient 
signaling, while apical exposure leads to sustained signaling [86], even though receptors 
at the basolateral and apical surfaces have similar abilities to activate signaling [87].   
EGFR activation induces the Tyr phosphorylation of β-catenin. Yasmeen et al. 
demonstrated that the phosphorylation of β-catenin leads to dissociation of the E-





Takahashi et al. showed that both E-cadherin and β-catenin were accumulated at 
the cell-cell junction and interacted with each other in confluent monolayers of human 
breast epithelial cells (HBE). Tyrosine phosphorylation of β-catenin was reduced when 
non-confluent cells became confluent, however overall levels of the proteins were 
essentially the same. This suggests that for confluence and proper monolayer formation 
β-catenin must be unphosphorylated [89]. It was also shown that β-catenin was Tyr 
phosphorylated to a greater level when cells were apically exposed to EGF as compared 
to basolateral exposure [87].  
Previous research in our lab has shown that EGFR transactivation, induced by the 
presence of either pili or opa, is required for invasion of GC into non-polarized cells. GC 
induces increased shedding of EGFR ligands and leads to activation of the downstream 
protein Erk [90]. Activation of EGFR leads to disruption of the junctional complex via 
phosphorylation of the junctional protein β-catenin [79] and in polarized cells the usually 
basolaterally localized EGFR is recruited to GC on the apical surface [90].  
 
1.5 Pathogens and the apical junction 
The epithelium is a critical barrier that prevents pathogenic entry into the human 
body. Pathogens have evolved means to directly or indirectly breach this barrier by 
affecting the apical junction. Interference with cell-cell junctions destabilizes the 
structure and function of the epithelium and facilitates the paracellular passage of the 
pathogen across the protective epithelium into deeper tissues. There are generally four (4) 




extracellular portion of the junctional proteins. Vibrio cholerae secretes the 
metalloprotease hemagglutinin/protease (HA/P) that cleaves the extracellular domain of 
occludin [46]. Bacteroides fragilis secretes a metalloprotease that cleaves the 
extracellular domain of E-cadherin and induces the proteolysis of the intracellular domain 
[91]. 2) Secretion of toxins that enter epithelial cells by endocytosis and alter intracellular 
signaling. Clostridium difficile produces toxins A and B that inactivate RhoA, causing 
actin reorganization and dissociation from the junctional complex. ZO-1 and occludin 
then dissociate from the TJ and cause a decrease in TER [46, 91]. Helicobacter pylori 
uses its type IV secretory system to inject the effector CagA into epithelial cells where it 
becomes phosphorylated and gains the ability to interact with ZO-1 at the junctional 
complex. Additionally CagA induces the internalization and redistribution of E-cadherin, 
which disrupts the AJ [91]. 3) Injection of proteins that directly destabilize the junctional 
complex. Vibrio cholerae produces the zonula occludin toxin (Zot), which increases the 
permeability of the TJ [46]. Clostridium perfringens produces the toxin CPE that binds to 
claudin leading to its degradation [91]. Listeria monocytogenes expresses the surface 
protein InA and InB. InA interacts with E-cadherin and induces the redistribution of α 
and β-catenin away from the AJ. InB disrupts the apical junction by inducing actin 
reorganization via activating PI3K [91]. 4) Pathogen invasion and direct interaction with 
the junctional complex. Escherichia coli has been shown to cause TER decreases and 
ZO-1 and occludin dissociation from TJ [46, 91]. Toxoplasma gondii accumulate around 
the junctional complex as an essential part of pathogenesis and are able to cross the 
epithelial barrier. It has been suggested that it is able to disrupt the junctional barrier 




The interaction of GC with polarized epithelial cells has not been well studied, so 
whether GC are capable of interfering with the apical junction and disrupting the 
epithelial barrier is not known. Early organ culture studies of the male urethra have 
shown GC in the subepithelial connective tissue. Penetration into underlying tissues can 
occur via the intercellular spaces, as these spaces appear to be larger in the areas directly 
affected by GC [7]. No studies in polarized cells have exclusively examined the effect of 
GC on the junctional complex. The ‘gate’ function of the junction has been peripherally 
analyzed in conjunction with transmigration analysis, but a detailed look at GCs effect on 
junctional proteins has not been undertaken. Transmigration of the other pathogenic 
Neisseria species, Neisseria meningitidis, shows direct effects on the junctional proteins. 
Endothelial cells show recruitment of ZO-1, ZO-2 and claudin (TJ proteins) and VE-
cadherin, p-120 catenin and β-catenin (AJ proteins) away from the junction and targeted 
to sites under the bacterial microcolonies [92]. Occludin was cleaved and disassociated 
from the membrane into the cytoplasm [93]. These findings suggest that GC may have a 
similar effect on epithelial junctional proteins and my project elucidated these effects. 
 
1.6 Hormone Receptors  
The barrier function of the epithelial cells in the female reproductive tract (FRT) 
is regulated by the hormonal cycle via hormone receptors. Over the course of the 
menstrual cycle the female sex hormones estrogen and progesterone fluctuate (Fig. 5).  
The menstrual cycle begins on the first day of vaginal bleeding. Both hormones are at 



























Figure 5. Estrogen and progesterone levels over the course of a menstrual cycle. 
The levels of both estrogen and progesterone vary as the menstrual cycle progresses 
peaking at two independent stages of the cycle. Both the peaks and the approximate 





at ~ 0.2 ng/ml on day 13. Levels steeply decline and begin to rise again, peaking at the 
lower level of 0.1 ng/ml on days 20-22. Progesterone levels remain low until day 14 
when they slowly begin to rise, peaking on day 20-22 at ~9 ng/ml. If conception does not 
occur both estrogen and progesterone levels rapidly decline and the cycle restarts [94-96]. 
The presence of estrogen and progesterone has been shown to affect the actin 
cytoskeleton [97, 98] and to increase occludin cleavage [99] thus decreasing the barrier 
function of the genital cells. During the later stages of the cycle when progesterone is at 
an elevated level the endometrial epithelium thickens, however the intercellular spaces 
are also increased [94].  
Estrogen (ER) and progesterone (PR) receptors are two of the major hormonal 
receptors. They are part of the nuclear receptor (NR) superfamily, specifically Class I 
NRs [100]. There are three major functional regions: a N-terminal transactivation domain 
(AF1) that functions independent of ligands, a central DNA binding domain (DBD) that 
is also responsible for receptor dimerization, and a C-terminal hormone binding domain 
(HBD) that also serves as an interaction site for co-activators and co-repressors. Another 
transactivation domain (AF2) and a hinge region connect the HBD and DBD (Fig. 6) 
[100, 101]. There are two isoforms of both the ER and PR. The ER subtypes (ERα and 
ERβ) are from two different genes, where as the PR isoforms (PR-A and PR-B) arise 
from a single gene that has two different promoters leading to the production of two 
separate mRNAs [102].  
The DBD and HBD of the two ER subtypes share high homology but the N-
terminus with its multiple Ser/Thr phosphorylation sites and AF1 domain, has little 
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Figure 6. Estrogen and progesterone hormone receptors. (A) ER and PR have 
high a homology to each other at the DBD, with significantly reduced homology at 
the other domains. (B)  Activated ER can signal through the ‘classical’ pathway 
that leads to transcription or the ‘non-classical’ pathway that can lead to rapid 
events due to activation of numerous signaling cascades. AF – Trans-activation 
domain, DBD – DNA binding domain, H – Hinge region, HBD – Hormone 





thus improper ligand activation. While they recognize similar DNA sequences and 
respond in a similar manner to the presence of 17β-estradiol, they are functionally 
distinct and expressed at levels in different tissues [100, 102]. ERα is a more potent 
transcription activator than ERβ and ERβ is capable of reducing transcriptional activity 
of ERα [102]. 17β-estradiol is the main ER ligand and plays a significant role in sexual 
development, behavior, reproductive functions, proliferation and differentiation. It binds 
with high affinity to ER, while its metabolic products such as estrone and estriol bind 
with a much lower affinity. The effect of 17β-estradiol can be pharmacologically 
attenuated by the use of anti-estrogens, ER antagonists i.e. ICI 182780 and selective 
estrogen receptor modulators (SERMs) i.e. tamoxifen [100, 103].    
PR-A and PR-B have almost identical DBD and HBD, however PR-A has a 
truncated N-terminus that is missing 164 aa. PR-B is a strong transcription activator 
while PR-A, in a manner similar to ERβ, can attenuate the activity of not only PR-B, but 
also other members of the NR family including the ER. The truncated segment of PR-A 
contains a third transcription activation domain (AF3), which is responsible for the 
increased activity observed in PR-B [100, 102]. Similar to the ERs, both PR-A and PR-B 
are co-expressed in most cells but the ratio depends on the cell type and conditions [102]. 
The physiological ligand of PRs is progesterone and it plays a major role in 
differentiation of the endometrium, in preparation of the uterus for implantation and 
maturation of mammary epithelium. Mifepristone (RU486) is a pharmacological PR 
antagonist that is commonly used as a contraceptive and in the treatment of benign 





Traditional or ‘classical’ signaling through the NRs results from the binding of 
lipophilic ligands diffused through the plasma membrane to the HBD of the receptors. 
This binding induces conformational changes and homo- or hetero-dimerization of the 
receptors, which leads to its dissociation from cytoplasmic chaperone proteins i.e. heat 
shock proteins (Hsp) and exposure of its nuclear localization sequence (NLS). The NLS 
directs receptor dimers to translocate into the nucleus where they bind to hormone 
response elements (HRE, also called steroid response elements (SRE)) and activate 
transcription of target genes [100, 105]. 
In addition to classical signaling, ‘non-classical’ signaling by the hormones has 
been observed. This signaling facilitates a more rapid response to the presence of the 
hormone, usually within seconds to minutes [100]. This signaling can be initiated by 
interaction between the ligand and the classical hormone receptor or may not involve the 
classical receptor but another plasma membrane receptor such as the G protein-coupled 
receptor (GPCR), GPR 30. This receptor has been shown to interact with estrogen, but 
whether it does this alone or within a protein complex is not known [106, 107]. A 
hallmark of the non-classical pathway is that its activity is not affected by the use of 
steroid antagonists [100]. 
Estrogen has been shown to activate the surface receptor, EGFR. 17β-estradiol 
leads to the transactivation of EGFR via the G-protein coupled receptor homolog, 
GPR30. This process requires the release of HB-EGF and is enhanced not inhibited by 
the presence of the ER antagonist ICI182780. This transactivation of EGFR was 





1.7 Sex hormones and genital epithelial cells 
The female reproductive tract can be separated into two regions based on their 
anatomic location: the lower tract consisting of the vagina and ectocervix and the upper 
tract consisting of the endocervix, endometrium and fallopian tubes. While the lower 
reproductive tract is mainly covered with stratified squamous epithelium that can be as 
thick as 25 layers of epithelial cells, the upper tract is lined with a single polarized layer 
of columnar epithelial cells [108]. The epithelium lining the female reproductive tract 
undergoes reorganization over the course of the menstrual cycle. In the endometrium, as 
estrogen levels initially increase there is a gradual thickening of the layer. This thickening 
is further advanced and attains its maximum thickness as progesterone levels increase. 
Withdrawal of estrogen and progesterone leads to shedding of the functional layer of the 
endometrium and initiation of the menstrual cycle [94, 109-112]. All layers of vaginal 
squamous epithelial cells proliferate as estrogen levels increase. At mid cycle, as estrogen 
levels decrease and progesterone begins to increase the superficial layers become smaller 
[94]. Cervical mucus production is also regulated by the menstrual cycle. In the early 
stages of the cycle (higher estrogen concentration) the cervix secretes a large amount of 
clear, thin watery mucus. As progesterone concentration increases later in the cycle the 
quantity of secreted mucus reduces and becomes a cloudy, viscous substance [95].  
Both the lower and upper tracts can be targeted by STIs [2, 113]. The vagina and 
ectocervix undergo continuous sloughing of additional layers providing a strategy to 
prevent pathogens from establishing an infection and colonizing. Continuous apical 
junctional complexes between neighboring cells hold the single layer of columnar 




against the passage of pathogens to the underlying cells and tissues. Whether the lower or 
upper tract is easier for sexually transmitted pathogens to colonize is up for debate, 
because while the sloughing is a good mechanical deterrent, the lower tract has a larger 
surface area for pathogens to access [113]. 
Most sexually transmitted pathogens first encounter the lower reproductive tract 
and can move upwards to cause disease [114]. The most vulnerable location in the genital 
epithelium is the ‘transitional or transformation zone’ between the ecto and endo cervix 
where the squamous epithelium changes to the single layer columnar epithelium [2]. Both 
the squamous and columnar epithelial cells are responsive to pathogens and their 
responses can be regulated by the female sex hormones, estrogen and progesterone [108]. 
In rodents and Rhesus models, progesterone has been shown to increase susceptibility to 
viral STIs, while estrogen provides protection or decreases the risk of viral infection. This 
correlates with the abilities of estrogen and progesterone to respectively, thicken or thin 
the stratified squamous epithelium of the vagina, and by extension strengthen or weaken 
the epithelial barrier against STIs in these animals. In humans the effect of progesterone 
appears to be less destructive to the epithelial lining than in animal models [115].  
 
1.8 Sex hormones and sexually transmitted infections 
Sexually transmitted infections (STIs) caused by bacteria or protozoa (i.e. 
gonorrhea, chlamydial infection, syphilis, chancroid) can generally be cured by single 
dose or short treatments of antibiotics. While these infections occur worldwide among all 
sexually active groups, there are significantly more infections among young people in 




time that it takes to obtain treatment. Some infections such as chlamydial and gonococcal 
infections are often asymptomatic and thus remain untreated and persist for longer 
periods of time. Importantly, STIs of bacterial pathogens, such as GC can facilitate an 
increase in the transmission of human immunodeficiency virus (HIV), both its infectivity 
and susceptibility. Additionally, STIs that cause genital discharge (e.g. gonorrhea) 
increase shedding of HIV [116]. With antibiotic resistant strains of these pathogens, like 
GC, on the rise, these previously curable STIs are now an emerging health crisis [117].  
It well known that sex hormones influence our susceptibility to STIs. Brabin et al. 
show that the stage of the menstrual cycle and usage of hormonal contraceptives 
influence susceptibility to STIs such as GC, Herpes simplex virus (HSV), HIV and 
chlamydia [114, 115]. Studies in rhesus monkeys show that progesterone implants make 
the animals more susceptible to simian immunodeficiency virus (SIV), while estrogen 
protects against it [118, 119]. In addition to regulating epithelial cells, sex hormones are 
also capable of regulating the immune response against sexually transmitted bacteria and 
viruses [2]. The FRT secretes antimicrobials, chemokines and cytokines in an effort to 
protect itself against invading pathogens. These molecules are constitutively produced, 
but production can be enhanced when pathogens are detected. Production of these 
protective molecules appears to follow the estrogen cycle, peaking and ebbing at the 
same time as estrogen levels [120]. This strongly suggests that estrogen stimulates 
antibody production and cell-mediated immune responses especially in the early stages of 
an infection. Whether estrogen provides a protective or harmful effect apparently depends 
on the infecting organism and stage of infection [114]. Murine models of infection of 




infection, due to the short menstrual cycle of the mouse. Chlamydia and herpes infection 
models require progesterone treatment [121, 122], while the GC infection model requires 
estrogen treatment [123]. The multiple regulatory roles of the hormones in the 
reproductive tract hinder the application of the mouse model in sexually transmitted 
pathogen research.  
Clinical studies have demonstrated a role for hormone contraceptives in STIs. 
Bacterial vaginosis (BV), which affects from 29% to as much as 50% of the female 
population, has been shown to be associated with increased acquisition of STIs. Oral 
contraceptives have been shown to decrease the risk of BV onset and enhance its 
remission [124, 125]. Initial exposure of hormonal contraceptives increases immunity to 
human papilloma virus (HPV), however once a persistent infection has been established 
the protective effect is lost [114]. The role of hormonal contraceptives on HIV infection 
has been controversial. Most of the cohort studies that involved sex workers from 
developing countries showed an increase in susceptibility to and accelerated disease 
progression of HIV coinciding with contraceptive use [126, 127]. However, another 
study, by Morrison et al. in 2007 showed that contraceptive use has no effect on women’s 
susceptibility to HIV. Reanalysis of the statistics in 2010 showed that the injected 
progesterone only contraceptive, DMPA, but not oral contraceptives, increased HIV 
susceptibility [128, 129]. Contraceptives up-regulate HIV co-receptors in the female 
genital tract [130]. The majority of contraceptive chlamydia studies show that oral 
contraceptive use increases the risk of infection [131, 132].  
Studies of hormonal effects on GC infection on the other hand are less consistent. 




infections [131]. Cohort studies that take sexual behavior into account show that oral 
contraceptives increase the risk of contracting gonorrhea [132] and asymptomatic female 
patients have increased blood progesterone levels [133]. Contrary to those reports, a 
study by Gursahaney et al. show that oral contraceptive users actually had a reduced risk 
of contracting gonorrhea from male partners diagnosed with the infection. This suggests a 
protective role for hormones in gonorrhea transmission [134]. It has been clinically 
shown that gonococcal PID and DGI occur more frequently during menses, implying that 
hormone levels may play a role in gonorrhea infectivity. Additionally, GC growth is 
enhanced in menstrual blood that is iron rich, and use of contraceptives reduces blood 
flow, thus decreasing the iron supply in the genital tract. How the regulatory roles of the 
hormones on genital epithelial cells and mucosal immunity impact GC transmission and 
infectivity is largely unknown. The combination of clinical and basic research is required 
for a comprehensive understanding of GC infection in this unique, hormonally controlled 
environment.    
 
1.9 Rationale 
The goal of my PhD study is to obtain a better understanding of the interaction of 
Neisseria gonorrhoeae with polarized epithelial cells during the infection process and the 
impact of the female sex hormones on this interaction. My study is a part of the 
collaborative interest of the Song and Stein labs in the progression of GC infection in 
women. The high infection rate and serious sequeale of the infection in young women is a 
significant public health concern. The invasive infection in women, which can lead to 




reproductive tract and invasion of GC into subepithelial tissue. N. gonorrhoeae is an 
obligate human pathogen and currently there is no good animal model for my study. An 
available mouse model requires high doses of estrogen to maintain a transient infection 
and therefore is not suitable for investigating how human sex hormones affect the 
initiation of the infection and progression of the disease. Most previous in vitro studies 
have focused on the interaction of GC with non-polarized epithelial cells. How GC 
interact with polarized epithelium lining the upper reproductive tract has not been well 
studied. I have developed a polarized model of two epithelial cell lines, an endometrial 
epithelial cell line HEC-1-B and a colonic epithelial cell line T84, both of which have 
been extensively used in the pathogenesis research field. The GC MS11 pili positive, opa 
positive strain was derived from a male patient. Using these polarized epithelial cell lines 
and GC strain, I have tested my hypothesis that GC cause activation of EGFR, leading to 
disruption of the junctional complex and increased GC transmigration across the 




1.10.1 Aim 1 
This aim was designed to examine the hypothesis that N. gonorrhoeae affects the 
junctional complex in a manner that requires activation of host cell surface receptor(s). I 
show that GC disrupt the localization of both tight junction and adherens junction 
proteins and that epidermal growth factor receptor (EGFR) activation is involved. 





1.10.2 Aim 2 
This aim was designed to examine role of the female sex hormones, estrogen and 
progesterone, on N. gonorrhoeae pathogenesis. I show that while the hormones have no 
effect on the early stages of GC pathogenesis, adherence and invasion, they facilitate an 





















Chapter 2: Neisseria gonorrhoeae Breaches the Apical Junction of 
Polarized Epithelial cells for Transmigration by Hijacking EGFR 
 
2.1 Introduction 
 Neisseria gonorrhoeae causes gonorrhea, a common sexually transmitted 
infection (STI). This gram-negative, obligate human pathogen causes different disease 
sequelae in men and women. The highest reported cases of gonorrhea are among teenage 
girls and young women [6]. Since most gonococcal (GC) infections in women are 
asymptomatic, the infections remain undiagnosed and untreated, thus predisposing 
women to pelvic inflammatory disease (PID) and disseminated gonococcal infection 
(DGI), which can lead to infertility and arthritis, respectively [3, 6, 9].  Clinical studies 
show an association of GC infection with an increased risk of HIV infection [135, 136], 
highlighting the significance of GC infection in public health. No vaccine has been 
successfully developed due to a lack of understanding of the cellular mechanism 
underlying the interaction of this bacterium with the mucosal surface of the female 
genital tract. 
 In women, the primary target of GC is the epithelial cell monolayer that lines the 
reproductive tract [4, 7]. The interaction of GC with epithelial cells has been extensively 
studied, primarily using non-polarized epithelial cell lines or organ culture. Initiation of 
colonization is mediated by pili, which bind to host surface receptors on columnar 
endocervical epithelial cells. Subsequent contraction of pili brings the bacteria close to 
the epithelial cells [4, 8, 137], allowing GC to establish a more intimate attachment to the 




epithelial cells, these interactions induce a variety of signaling cascades, including 
calcium flux, phosphoinositide 3-kinase (PI3K), phospholipase C (PLC) and the mitogen-
activated protein kinase (MAPK) Erk, leading to actin reorganization, microvillus 
elongation and the subsequent engulfment of GC [4, 28]. We have shown that the 
interaction of GC with human endometrial epithelial cells, HEC-1-B, increases the 
phosphorylation of epidermal growth factor receptor (EGFR) by triggering the expression 
and surface cleavage of EGFR ligands. This GC-induced EGFR trans-activation is 
required for GC invasion into non-polarized HEC-1-B cells. In addition to EGFR 
phosphorylation, apical inoculation of GC leads to a redistribution of EGFR from the 
basolateral surface of polarized HEC-1-B cells to GC adherent sites at the apical surface 
[90]. Cleavage of these EGFR ligands generally occurs through activation of matrix 
metalloproteinases (MMPs) or the related a disintegrin and metalloproteinase (ADAM) 
[138-140], and inhibition of this cleavage activity reduce the invasion of GC into host 
epithelial cells [89]. 
 In addition to attachment and invasion, GC are capable of transmigrating across 
polarized epithelial cells cultured in vitro [17, 34, 35, 141].  Subepithelial bacteria have 
been found in organ culture models and clinical samples from patients [13, 142, 143]. 
This suggests that GC transmigration is associated with the pathogenicity of the bacteria, 
however the cellular mechanism underlying GC transmigration is largely unknown. 
Based on the invading capability of GC, it has been proposed that GC transmigrate via an 
intracellular pathway, in which apically internalized GC traverse to and exit from the 




 The single layered endocervical columnar epithelial cells have been shown to be 
the preferred tissue target for GC infection. The monolayer of epithelial cells on the 
mucosal surface is held together via apical junction complexes formed continuously 
between neighboring cells. The apical junction complexes seal the paracellular space 
between epithelial cells, creating a physical barrier against pathogen movement via the 
space between cells. The apical junction also provides a barrier against the lateral 
movement between the apical and basolateral membrane, generating and maintaining the 
polarized distribution of proteins and lipids in the apical or basolateral membrane and 
their distinct physiological functions [46, 51, 144]. The actin cytoskeleton provides 
scaffolding supports for microvilli and the apical junction [45, 52, 57, 60, 145]. The 
apical junction contains the tight junction and adherens junction [49, 57]. The tight 
junction consists of transmembrane proteins such as occludin and claudins [46, 144] and 
associated protein ZO-1 that links the tight junction to the actin cytoskeleton [45, 57]. 
The adherens junction is formed through calcium dependent trans-homophilic interaction 
of E-cadherin on neighboring cells [146, 147] and is required for the assembly of the tight 
junction. Therefore, removing extracellular calcium leads to the disassembly of the apical 
junction [78]. The apical junction is a dynamic structure and its barrier function as well as 
assembly and disassembly are regulated by external and internal cell signaling through 
junction-associated proteins, such as β-catenin [51, 144, 148, 149]. Signaling mediated 
by surface receptors, such as EGFR [79, 87], induces the phosphorylation of β-catenin, 
which causes the dissociation of β-catenin from the junctional complex and the actin 
cytoskeleton [58, 89, 150, 151]. Endocytosis and lysosomal degradation of the junctional 




 In order to establish infection, GC must attach to epithelial cells. Invasive diseases 
may require GC invasion into and/or transmigration across polarized epithelium. While 
the interaction of GC with non-polarized epithelial cells has been extensively studied, 
how GC interaction with polarized epithelial cells impacts the epithelial barrier has not 
been fully investigated. Many mucosal bacterial pathogens, including Clostridium 
difficile, Escherichia coli, Vibrio cholerae, Helicobacter pylori, Clostridium perfringens, 
Listeria monocytogenes and Bacteroides fragilis, have developed means to weaken the 
epithelial barrier by directly or indirectly regulating the apical junction. The interaction of 
these pathogens with polarized epithelial cells disrupts the integrity of the junctional 
complex and increases epithelial permeability, which facilitate the passage of pathogens 
through the paracellular space [46, 91]. Furthermore, N. meningitidis, the other 
pathogenic species of Neisseria, transmigrates across endothelial cells by disrupting VE-
cadherin-based intercellular junctions [92, 93].  
 In this study, we examine the interaction of GC with polarized epithelial cells. We 
observed that apical inoculation of GC induces the disassembly of the apical junction, 
which is concurrent with a decrease in the barrier function of the apical junction against 
the lateral movement between the apical and basolateral membrane. GC-induced junction 
disassembly depends on the kinase activity of EGFR. Disrupting the apical junction using 
the calcium chelator, EGTA, increases GC transmigration. Inhibition of GC-induced 
junction disassembly by an EGFR kinase inhibitor significantly reduces GC 
transmigration. These results provide the first evidence that GC can negatively regulate 





2.2 Materials and Methods 
2.2.1 Epithelial Cells 
 Human endometrial adenocarcinoma cell line, HEC-1-B cells (ATCC# HTB-113, 
Manassas VA, USA), were maintained in Eagles MEM, alpha medium supplemented 
with 10% heat inactivated fetal bovine serum (FBS). Human colorectal carcinoma cell 
line, T84 cells (ATCC# CCL-248), were maintained in Dulbecco's modified Eagle's 
medium:Ham F12 (1:1) supplemented with 7% heat inactivated FBS. Cells were 
maintained at 37 °C and 5% CO2. Cells were seeded at 6x104 (6.5 mm diameter 
transwell) or at 1x105 (24mm diameter transwell) per transwell (3 µm pore size, polyester 
transwells inserts, Corning, Lowell, MA, USA) and cultured for ~10 days until 
transepithelial electrical resistance (TER) reached ~400 Ω (HEC-1-B) and ~2000 Ω 
(T84). TER was measured using a Millicell ERS volt-ohm meter (Millipore, Bedford, 
MA, USA).  
 
2.2.2 Neisseria Strains 
 N. gonorrhoeae strain MS11 that expressed both pili and Opa (Pil+ Opa+) were 
used. Gonococci (GC) were grown on GC media base plates with 1% Kellogg’s 
supplement (GCK) [154] for 15–18 h before inoculation. Pil+ Opa+ colonies were 
acquired based on their morphology using a dissecting light microscope. Bacteria were 
placed in suspension and the concentration determined using a spectrophotometer. An 
OD of 1 represented 109 GC. Gentamicin killed GC were generated by incubating the 
bacteria with 100 µg/ml gentamicin sulfate for 4 h at 37 °C and then overnight at 4 °C. 




2.2.3 Immunofluorescence analysis 
 Cells were serum starved overnight, pre-treated with or without the EGFR 
inhibitor AG1478 (10 µM, Calbiochem, San Diego, CA, USA) for 2 h, and incubated 
with GC in the presence or absence of the inhibitor for 6 h. Cell were washed and fixed 
using a pH shift method [155], permeabilized, and stained with anti-ZO-1 (BD 
Bioscience, Bedford, MA, USA), anti-occludin (Invitrogen, Camarillo, CA, USA), anti-
β-catenin (Millipore, Temecula, CA, USA), and anti-GC [156] antibodies. Cells were 
analyzed by confocal fluorescence microscopy (Zeiss LSM 510 or 710, Carl Zeiss 
Microscopy LLC, Thornwood, NY, USA). Z-series of images were obtained in 0.5 µm 
slices from the top to the bottom of cells, and three-dimensional (3D) composites 
obtained. Fluorescence intensity profiles were generated using the ImageJ software. The 
percentage of cells showing discontinuous staining of junctional proteins was determined 
by visual inspection of multiple image slices. The redistribution of β-catenin from the 
apical junction to the cytoplasm was quantified by the fluorescence intensity ratio (FIR) 
of β-catenin at the cell-cell junction to that at the cytoplasm using fluorescence intensity 
profiles generated by the ImageJ software. 
 
2.2.4 Immunoprecipitation and immunoblotting analyses 
 Polarized epithelial cells apically incubated with bacteria for varying periods were 
lysed using RIPA buffer [90]. The cell lysates were incubated with protein A Sepharose 
beads (GE Heathcare, Piscataway, NJ, USA) and anti-β-catenin (Millipore) or anti-
phosphotyrosine mAb (4G10) (Millipore) Abs. Immunoprecipitates were resolved by 




immunoprecipitation, the blots were probed for phosphotyrosine using 4G10 mAb to 
determine phosphorylated β-catenin. For phosphotyrosine immunoprecipitation, the blots 
were probed for EGFR (Santa Cruz, CA, USA). The total levels of β-catenin and EGFR 
in the cell lysates were detected by western blotting using specific antibodies. The blots 
were imaged using Fujifilm’s LAS-3000 (Valhalla, NY, USA) and quantified by 
Fujifilm’s MultiGuage software.   
 
2.2.5 Functional analyses of the apical junction 
 To determine the effect of GC on the fence function of the apical junction against 
lateral mobility between the apical and basolateral membrane, HEC-1-B cells were 
seeded at 1x105 on the underside of transwells and cultured for 10 days until TER 
reached the optimal level (~400Ω). GC were added to the apical surface and incubated 
for 4 h. Time lapse xz images were acquired in the presence of the CellMask dye (5 
µg/ml, Invitrogen), (excitation and emission wavelengths were 554 and 567 respectively), 
to mark the apical membrane for 30 min using the Leica TCS SP5 X confocal microscope 
(Leica Microsystems, Inc, Buffalo Grove, IL, USA). Over the course of the imaging the 
cells were enclosed in a humidifying chamber at 37 °C and exposed to 5% CO2. The 
fluorescence intensity ratio of the CellMask dye at the apical to basolateral membrane 
was determined.  
To determine the effect of GC on the gate function of polarized epithelial cells 
against the diffusion of molecules through the paracellular spaces, cells were incubated 
with GC and Lucifer Yellow (500 µM, Sigma, Saint Louis, MO, USA) or FITC (50 µM, 




of Lucifer Yellow (excitation 425nm, emission 528nm) and FITC (excitation 490nm, 
emission 525nm) in the apical and basolateral media was determined using a fluorometer. 
All readings were taken at room temperature.  
 
2.2.6 GC invasion and transmigration assays 
 Polarized epithelial cells were incubated apically with GC for 6 h at 37 °C. When 
the EGFR inhibitor was used, cells were pretreated with AG1478 (10 µM) for 2 h and 
incubated with GC in the presence of the inhibitor. Media from the basal compartment 
was collected and plated onto GCK to determine the number of transmigrated bacteria. 
Cells were exposed to gentamicin (100 µg/ml) for 2 h to kill extracellular bacteria, then 
lysed and plated to determine invaded bacteria.  
 
2.2.7 Statistical analysis 
Statistical significance was assessed using the Student t-test by Prism software 




2.3.1 Preferential localization of live gonococci at the cell-cell junction of polarized 
epithelial cells. 
 To investigate the interaction of gonococci (GC) with polarized epithelial cells, 
we used confocal microscopy to analyze the distribution of GC on HEC-1-B and T84 




The polarization of these cells was confirmed by a measured increase in the 
transepithelial electric resistance (TER) and the visualization of the polarized distribution 
of apical junction proteins. After apical inoculation of GC (live or gentamicin killed at 
MOI of 10 or 20, respectively) for 6 h, the polarized epithelial cells were stained for the 
apical junctional protein ZO-1 and for GC, and analyzed using three-dimensional (3D) 
confocal fluorescence microscopy. The percentage of GC clusters located in the vicinity 
of the cell-cell junction marked by ZO-1 was determined by visual inspection. The data 
show that approximately 80% of live GC clusters, but only 40-50% of killed GC clusters, 
localized at the cell-cell junction of both HEC-1-B and T84 cells (Fig. 7). This result 
indicates that GC preferentially localize at the apical cell-cell junction in polarized 
epithelial cells despite their different levels of polarity and tissue origins, and this 
localization is more efficient when the bacteria are viable.  
 
2.3.2 GC inoculation disrupts the continuous apical junctional complexes between 
polarized epithelial cells 
 The preferential cell-cell junctional location of GC implicates a possible impact of 
GC on the apical junction of polarized epithelial cells, similar to phenomena observed in 
other mucosal bacterial pathogens [157-163]. To examine the effects of GC on the 
distribution of apical junctional proteins, polarized HEC-1-B (Fig. 8) and T84 (Fig. 9) 
cells were incubated with GC in the apical compartment for 6 h and stained for the apical 
junctional protein, ZO-1 or occludin. Fluorescence intensity (FI) profiles of ZO-1 and 
occludin were generated from images acquired by confocal microscopy. In the absence of 
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Figure 7. Live GC preferentially localize at the cell-cell junction of polarized 
epithelial cells.  Polarized HEC-1-B and T84 cells were apically inoculated with 
live or gentamicin killed GC (P+O+ MS11) at a MOI of 10 and 20, respectively, for 6 
h. Cells were fixed, permeabilized and stained for ZO-1 and GC, and analyzed using 
confocal microscopy. The number of GC clusters localized at (long arrows) or not at 
(arrow head) the cell-cell junction marked by ZO-1 in HEC-1-B and T84 cells was 
quantified by visual inspection. Shown are representative images (A) and the 
average percentages (±S.D.) of GC clusters at the cell-cell junction (B) from three 
independent experiments. Scale bar, 10 µm. **, p≤ 0.01.  
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Figure 8. Viable but not killed GC disrupt the continuous apical junction 
location of ZO-1 and occludin in polarized HEC-1-B cells. Polarized HEC-1-B 
cells were incubated with media only (a and d), live GC (b, c, e, and f) or gentamicin 
killed GC in the apical compartment for 6 h. Cells were fixed and stained for ZO-1 
(A) or occludin (B) and GC, and then analyzed using confocal microscopy. Shown 
are representative images (composites of 1 µm slices) and their fluorescence 
intensity profiles. Cells with disrupted ZO-1 (C) and occludin (D) peripheral staining 
were quantified by visual inspection, and the average percentages (±S.D.) from three 
independent experiments are shown. Scale bar, 5 µm.  





























-      Live 
    -GC                                + GC             
ZO-1 / GC   
a b c 
d e 
A 
   -GC                              + GC          
Occludin/GC 
B 































Figure 9. GC inoculation disrupts the continuous apical junction location of 
ZO-1 and occludin in polarized T84 cells. Polarized T84 cells were incubated 
with media only (a) or GC (b-c) in the apical compartment for 6 h. Cells were 
stained for ZO-1 or occludin and GC and analyzed using confocal microscopy. 
Shown are representative images of ZO-1 (A) and occludin (B) and their 
fluorescence intensity profiles (d-e). Cells with disrupted ZO-1 (C) and occludin 
(D) peripheral staining were visually quantified, and the average percentages 
(±S.D.) from three independent experiments are shown. Scale bar 10 µm.  




resulted in significant redistribution of junctional complex proteins, with 78% and 53% 
of HEC-1-B cells showing discontinuous ZO-1 and occludin staining respectively. 
However, gentamicin killed GC that can attach to but not invade into non-polarized 
epithelial cells [156] had no significant effect on ZO-1 (Fig. 8C) and occludin staining 
(Fig. 8D). While the level of disruption of the apical junction in T84 cells appeared to be 
lower than that observed in HEC-1-B cells, GC interaction still increased the percentage 
of cells with discontinuous staining of ZO-1 and occludin from 0 to 18% and 33% 
respectively (Fig. 9). These results indicate that the inoculation of viable GC, but not 
killed GC, induces the disassociation of ZO-1 and occludin from the apical junction of 
polarized epithelial cells, suggesting a capability for GC to induce the disassembly of the 
apical junction during infection.  
 
2.3.3 GC inoculation decreases the fence but not gate function of the apical junction 
 GC-induced redistribution of the apical junctional proteins potentially affects the 
functionality of the junctional complex. The apical junction performs two significant 
roles in polarized epithelial cells. The ‘fence’ function prohibits proteins and lipids in the 
apical and basolateral membrane from laterally moving into the other side, thereby 
maintaining the functional polarity of two surfaces on epithelial cells. The ‘gate’ function 
controls the paracellular permeability of epithelial cells, preventing mucosal pathogens 
from crossing through the paracellular space between epithelial cells. To examine the 
fence function, polarized HEC-1-B cells were grown on the underside of transwells and 




























Figure 10. GC inoculation increases the lateral mobility between the apical and 
basolateral membrane, but not the permeability of the apical junction in polarized 
epithelial cells. (A-B) Polarized HEC-1-B were incubated with media alone (-) or GC 
(+) for 4 h. Cells were then apically exposed to the CellMask membrane dye, and live 
time lapse images were acquired using a confocal microscope. The apical to basolateral 
fluorescence intensity (FI) of the CellMask dye over time was determined (B). (C) 
Epithelial cells were incubated with or without GC for 6 h in the presence of Lucifer 
yellow or FITC dye. The fluorescence intensity of Lucifer yellow or FITC in the apical 
and basal compartments was determined using a luminometer. The basal compared to 
apical FI of Lucifer yellow and FITC, respectively, was determined. Shown are the 
represent images and the averages values (±S.D.) from three independent experiments. 
Scale bar, 5 µm. 
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apical chamber to stain the apical membrane exclusively, and cells were analyzed by time 
lapse microscopy. An increase of the CellMask staining in the basolateral surface was 
used as the indication of a decrease in the fence function of the apical junction. To 
quantify the lateral movement of the dye from the apical to the basolateral surface, we 
determined the Fluorescence Intensity Ratio (FIR) of the dye in the apical surface to that 
in the basolateral surface. In the absence of GC, the majority of the apically added 
CellMask dye remained at the apical region of epithelial cells with the FIR at ~33. This 
FIR decreased slowly over time and reduced to ~22 by 30 min post CellMask staining 
(Fig. 10A-B). In the presence of GC there was a rapid decrease in the CellMask dye in 
the apical membrane, with a concomitant increase in the CellMask dye in the basolateral 
region, leading to a reduction in the FIR from 33 to 9 within the first 5 min of staining 
(Fig. 10A-B). The FIR further decreased over time and by 30 min, the FIR in GC-
infected epithelial cells was reduced below 3 (Fig. 10A-B). These results show that GC 
inoculation significantly increases the lateral mobility from the apical to basolateral 
membrane, suggesting that GC induce a significant reduction in the fence function of the 
apical junction. 
 The effect of GC on the gate function of the apical junction was determined by 
measuring the permeability of epithelial monolayers to Lucifer yellow and fluorescein, 
which are dyes with small molecular masses. These dyes represent small molecules that 
can pass between the paracellular space of neighboring cells, a process/movement 
regulated by the apical junctional complex. Polarized HEC-1-B cells were incubated with 
the Lucifer yellow or fluorescein apically in the absence or presence of GC for 6 h. The 




quantitative measure of the apical to basal permeability. We found that GC inoculation 
had no significant effect on the amount of either lucifer yellow or fluorescein diffusion to 
the basolateral medium (Fig. 10C). Consistent with this finding, we did not detect 
significant decreases in TER after 6 h GC incubation (data not shown). Disrupting the 
apical junction with the calcium chelator EGTA significantly increased the amount of the 
dyes in the basal medium (data not shown). These results indicate that GC inoculation 
reduces the fence function of the apical junction, but it does not significantly alter the 
permeability of the epithelium.  
 
2.3.4  Phosphorylation and redistribution of β-catenin in GC-infected epithelial cells 
 The apical junction undergoes rapid assembly and disassembly in response to 
internal and external signals [144]. β-catenin provides a link between the apical junction 
and cellular signaling [51, 56, 164, 165]. To understand how GC regulate the apical 
junction, we examined the effects of GC inoculation on the phosphorylation and cellular 
distribution of β-catenin. Polarized HEC-1-B cells were incubated with or without GC in 
the apical chamber for 4 h. Phosphorylated β-catenin was detected and quantified using 
immunoprecipitation and western blot analysis. We found that the presence of GC 
significantly increased the phosphorylation level of β-catenin without altering its total 
protein level (Fig. 11A-B), suggesting that GC stimulates β-catenin phosphorylation. We 
used immunofluoresence microscopy to analyze the cellular distribution of β-catenin. 
The disassociation of β-catenin from the apical junction was quantified using the FIR of 
β-catenin at the cell-cell junction to that in the cytoplasm. β-catenin was concentrated at 




(Fig. 11C-H). When exposed to GC, there were increases in the cytoplasmic levels with 
parallel decreases in the junctional level of β-catenin, leading to reductions in the 
junction to cytoplasm FIR of the β-catenin staining in both polarized HEC-1-B and T84 
cells (Fig. 11C-H). Concurrent with the redistribution, a portion of β-catenin staining 
appeared to be colocalized with GC clusters (Fig. 11C and 11F), suggesting a recruitment 
of β-catenin to GC adherent sites. In contrast, incubation with gentamicin-killed GC for 
the same length of time did not affect the cellular distribution of β-catenin (Fig. 14C and 
14D). These results demonstrate that the presence of GC induces the phosphorylation and 
redistribution of β-catenin from the apical junction to the cytoplasm, and suggest that GC 
regulate the apical junction by modulating the activity of β-catenin. 
 
2.3.5 GC inoculation does not change the cellular level of junctional proteins 
 A common mechanism underlying the disassembly of the apical junction is the 
endocytosis and lysosomal degradation of junctional proteins. To determine if GC trigger 
such a mechanism, we compared the cellular levels of the junctional proteins, occludin 
and ZO-1, in polarized HEC-1-B cells with and without 6 h GC incubation. Using 
western blot analysis, we did not detect significant differences in the total protein levels 
of ZO-1 and occludin in GC inoculated epithelial cells in comparison to those without 
GC (Fig. 12). This result suggests that GC inoculation does not lead to a significant 
degradation of junction proteins, and that degradation of junction proteins is unlikely to 
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Figure 11. GC inoculation induces the phosphorylation and redistribution of 
β-catenin from the apical junction to the cytoplasm. (A-B) Polarized HEC-1-B 
cells were incubated apically with or without GC for 4 h. Cells were lysed and 
subjected to immunoprecipitation using β-catenin-specific antibodies. 
Immunoprecipitates were analyzed by SDS-PAGE and Western blot probing for 
phosphotyrosine. The blot was quantified by densitometry to determine the p β-
catenin fold increase over no GC control. (C-H) Polarized HEC-1-B (C-E) and 
T84 (F-H) cells were incubated with or without GC apically for 6 h. Cells were 
stained for β-catenin and GC and analyzed using confocal microscopy. 
Fluorescence intensity profiles along a line crossing cells (D and G) were 
generated to determine the β-catenin FI at the membrane compared to the 
cytoplasm (E and H). Shown are representative blots, images, fluorescent intensity 
profiles of the representative images, and the averages ratios (±S.D.) from three 
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Figure 12. GC inoculation does not change the cellular levels of junctional 
proteins. HEC-1-B cells were lysed and analyzed by SDS-PAGE and western 
blot, probing for junctional proteins, ZO1, and occludin, and β-tubulin as the 
loading control. Shown are representative blots (A) and the average 




2.3.6 Disrupting the apical junction with EGTA increases GC transmigration across 
polarized epithelial cells 
 The apical junction is essential for the mucosal epithelium’s barrier function. To 
investigate if junctional regulation is important for GC infection, we determined if 
disruption of the apical junction by EGTA has any effect on GC invasion and 
transmigration.  EGTA is a Ca2+ chelator that induces the disassembly of the apical 
junction by inhibiting Ca2+-dependent trans-homophilic interaction of E-cadherin on 
neighboring epithelial cells [78]. Polarized HEC-1-B cells were pre-treated with EGTA 
[5 mM] in both the apical and basal compartments for 10 min, and then the EGTA was 
removed by washing before GC inoculation in the apical compartment. EGTA pre-
treatment dramatically reduced TER and caused a complete loss of the polarized 
distribution of ZO-1, but did not affect the viability of GC (data not shown), confirming 
the efficacy of EGTA in junction disruption. After the 6 h incubation with GC, the CFU 
of GC recovered from the basal medium was increased 100 fold in EGTA-treated HEC- 
1-B cells, compared to cells without EGTA treatment (Fig. 13A). However, EGTA 
treatment did not significantly change the level of GC invasion into HEC-1-B cells (Fig. 
13B). Therefore, disrupting the apical junction increases GC transmigration across 
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Figure 13. Disrupting the apical junction by EGTA increases GC 
transmigration. Polarized HEC-1-B cells were pretreated with or without EGTA 
(5 mM) apically and basally for 10 min. Cells were then washed and inoculated 
with GC at a MOI of 10 for 6 h. The basal media was collected and plated to 
determine the transmigrated GC. Cells were also washed and incubated with 
gentamicin, then lysed and the bacteria collected and plated to determine invaded 
GC. Shown are the average values (±S.D.) from three independent experiments. 




2.3.7 GC-induced β-catenin redistribution depends on the kinase activity of EGFR  
 The increased phosphorylation level and redistribution of the junction signaling 
connecter, β-catenin, in GC inoculated epithelial cells suggest that GC potentially 
regulate the apical junction via activating host signaling cascades. Based on previous 
findings that GC inoculation increases EGFR phosphorylation [90] and that EGFR 
activation has been shown to lead to β-catenin phosphorylation [79, 89, 150], we 
hypothesized that GC-induced redistribution of β-catenin is related to EGFR activation. 
We examined whether GC inoculation impacts EGFR phosphorylation in 
polarized epithelial cells and if the EGFR kinase inhibitor, AG1478, has any effect on 
GC-induced redistribution of β-catenin. The phosphorylation of EGFR was determined 
by immunoprecipitation and western blot. Similar to our previous observations in non-
polarized cells [90], the level of phosphorylated EGFR in polarized HEC-1-B cells was 
increased after cells interacted with GC for 4 h, compared to media only controls (Fig. 
14A-B). To inhibit EGFR activation, polarized cells were pre-treated for 2 h with the 
EGFR kinase inhibitor AG1478 and then incubated with GC in the presence of the 
inhibitor for 6 h. Treatment with the EGFR inhibitor significantly reduced GC-induced 
redistribution of β-catenin from the membrane to the cytoplasm in both polarized HEC-1-
B and T84 cells, increasing the membrane to cytoplasm FIR of β-catenin from ~3 back to 
5 (Fig. 14C-D). Additionally, the treatment of the EGFR inhibitor reduced the 
colocalization between GC microcolonies and β-catenin for both polarized HEC-1-B and 
T84 cells (Fig. 14E and 14F). The inhibitory effect of the EGFR kinase inhibitor on GC-
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Figure 14. GC inoculation induces the phosphorylation of EGFR, which is 
required for GC-induced redistribution of β-catenin. (A-B) Polarized HEC-1-
B cells were incubated with or without GC for 4 h and then lysed. Cell lysates 
were subjected to immunoprecipitation using phosphotyrosine-specific antibody. 
Immunoprecipitates and the cell lysates were analyzed using SDS-PAGE and 
western blot, probing for EGFR and tubulin as loading controls. Shown are 
representative blots of three independent experiments (A). Densitometry analysis 
was performed to determine fold increase over control (B). (C-D) Polarized HEC-
1-B (C) and T84 (D) cells were untreated or pre-treated with the EGFR kinase 
inhibitor AG1478 (10 nM) for 2 h then apically incubated with live GC with or 
without the inhibitor or gentamicin killed GC for 6 h. Cells were stained for β-
catenin and GC and analyzed using confocal microscopy. The β-catenin FI of 
membrane compared to cytoplasm was determined as described in Fig. 4. 
Colocalization of GC microcolonies with β -catenin was analyzed for HEC-1-B 
(E) and T84 (F) polarized cells. Shown are the average ratios (±S.D.) from three 




suggests that GC-induced EGFR activation and its downstream signaling lead to the 
disassembly of the apical junction in GC-infected epithelial cells.  
 
2.3.8 Negative regulation of the apical junction by GC facilitates GC transmigration  
 To investigate whether GC-induced redistribution of junctional proteins and 
reduction in the fence function of the apical junction contribute to GC infection, we 
utilized EGF and the EGFR kinase inhibitor to manipulate the effect of GC on the apical 
junction. Treatment with EGF, which activates EGFR signaling cascades and promotes 
junction disassembly [166, 167] resulted in a ~5-fold increase in GC transmigration 
across polarized HEC-1-B cells, as compared to the untreated control cells (Fig. 15A).  
In contrast, treatment with the EGFR kinase inhibitor, which inhibits the negative effects 
of GC on the apical junction, led to a ~5-fold decrease in GC transmigration compared to 
untreated control cells and a ~10 fold decrease when compared to EGF treated cells (Fig. 
15A). T84 cells showed a similar increase and decrease in the presence of EGF and 
AG1478, respectively (Fig. 15B). These results suggest that GC-induced EGFR 
activation and the consequent disassembly of the apical junction facilitate the 
transmigration of GC across the epithelial monolayer.  
 
2.3.9 Invasion of polarized cells is not influenced by EGFR activation 
Previous research has determined that EGFR activation is involved in GC 
invasion into non-polarized cells [90]. Upon determining that transmigration across 









































Figure. 15. GC transmigration is EGFR dependent. Polarized HEC-1-B (A) 
and T84 (B) cells were untreated or pre-treated with the EGFR kinase inhibitor 
AG1478 (10 nM) or EGF (10 nM) for 2 h and 1 h respectively, then apically 
incubated with GC for 6 h in the presence or absence of AG1478 or EGF. The 
basal media was collected and plated to determine transmigrated CFU. Shown 
are the average values (±S.D.) of more than three independent experiments for 




also affected. Polarized HEC-1-B and T84 cells were pre-treated with EGF or AG1478 
for 1 h and 2 h respectively, then apically inoculated with live GC at MOI 10 for 6 h. 
Cells were washed, exposed to gentamicin for 2 h, lysed and invaded CFU determined. 
Neither EGFR activation (EGF) nor inhibition (AG1478) caused any significant change 
in the number of GC that invaded cells, in either HEC-1-B (Fig. 16A) or T84 (Fig. 16B). 
While these results were surprising considering the observed results in non-polarized 
cells, we had already observed from other data, (Wang unpublished data) that polarized 
cells do not necessarily replicate phenomena observed in non-polarized cells. These 
results suggest that disruption of the junctional complex via EGFR activation leads to GC 
transmigration without affecting invasion of GC into these cells.   
 
2.4 Discussion 
GC establish infection in the female genital tract primarily by interacting with the 
endocervical epithelial monolayer. This monolayer of columnar epithelial cells is highly 
polarized and held together by the apical junction. This study provides the first detailed 
examination of the interaction of GC with polarized epithelial cells and reveals unique 
mechanisms underlying this interaction. Our results demonstrate that GC interaction with 
polarized epithelial cells induces the disassembly of the apical junction, weakening its 
barrier function against the lateral movement between the apical and basolateral 
membrane but not its barrier function against paracellular permeability. The negative 
effect of GC on the apical junction is dependent on GC-induced EGFR activation, which 
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Figure. 16. GC invasion is unaffected by EGFR. Polarized HEC-1-B (A) and 
T84 (B) cells were untreated or pre-treated with the EGFR kinase inhibitor 
AG1478 (10 nM) or EGF (10 nM) for 2 h and 1 h respectively, then apically 
incubated with GC for 6 h in the presence or absence of AG1478 or EGF. 
Adherent bacteria were killed by gentamicin and invaded GC plated to determine 
CFU. Shown are the average values (±S.D.) from three independent experiments. 








weakening of the apical junction by GC facilitates their transmigration across polarized 
epithelial cells, contributing to GC pathogenicity. 
To establish infection, mucosal pathogens have to overcome our body’s first line 
of defense, the epithelium. Therefore, it is not surprising that many mucosal pathogens, 
such as enteric bacterial pathogens enterohemorrhagic E. coli, Salmonella and 
Helicobacter pylori, are capable of disrupting the apical junction that secures the 
epithelial physical barrier, thereby increasing the permeability of epithelial monolayers 
lining the lumen of the intestine [46, 91, 160, 161, 168, 169].  Meningococci have been 
shown to disrupt both occludin based tight junctions and VE-cadherin-based intercellular 
junctions of endothelial cells, providing a mechanism for meningococci to cross the brain 
blood barrier [92, 93, 170]. GC have been shown to induce the redistribution of E-
cadherin, but not the apical junctional proteins ZO-1 and occludin, in immortalized 
endometrial epithelial cells and isolated primary fallopian epithelial cells that are not 
polarized [171]. This study shows for the first time that the apical incubation of GC with 
polarized epithelial cells induces the protein redistribution of both adherens and tight 
junctions. Such redistribution was not only observed in low TER endometrial epithelial 
cells HEC-1-B, but also in colonic epithelial cells T84 that are highly polarized. 
 We examined how GC-induced redistribution of junctional proteins impacts the 
function of the apical junction. Different from the enteric bacterial pathogens and 
meningococus, GC-induced redistribution of the junctional proteins does not lead to a 
significant increase in the permeability of epithelial monolayers (gate function). Instead, 
it weakens the lateral mobility barrier between the apical and basolateral membrane 




membrane to move more freely into each other, consequently reducing or losing the 
polarized functional domains in epithelial cells. How GC manage to affect the fence 
function of the apical junction more than its gate function is unclear.  
Our findings that GC microcolonies preferentially localize at the cell-cell junction 
where junctional proteins such as β-catenin disassociate from support our hypothesis that 
the interaction of GC with multiple epithelia cells at their junction may prevent the 
expected free diffusion through paracellular space, even though GC promotes the 
disassembly of the apical junction. This occurs naturally when mucosal dendritic cells 
interact with polarized epithelial cells. The dendrites of the cells extend through the 
apical junction from the basolateral side to capture antigens at the apical surface, without 
increasing the permeability of the epithelium. This process is mediated by the direct 
interaction of junctional proteins expressed by dendritic cells with the apical junctional 
proteins of epithelial cells [172]. Whether the cell-cell junctional location of GC is 
mediated by direct interaction of GC with junctional proteins remains to be determined. 
 The dynamics of assembly and disassembly of the apical junction is tightly 
controlled by cell signaling [46, 71]. Many mucosal pathogens are capable of hijacking 
the host cell signaling apparatus to promote junction disassembly. For example, H. pylori 
injects CagA and other proteins via the type IV secretory apparatus into epithelial cells 
[173], where CagA targets to PAR1/MARK kinase complexes that play essential roles in 
epithelial cell polarity [174]. In the case of meningococcus, the bacteria disrupt the 
intercellular junction by activating β2-adrenoceptor/β-arrestin pathway in endothelial 
cells [175]. Here we show that GC induces EGFR activation in polarized epithelial cells, 




across polarized epithelial cells, depends on EGFR activation. Our previously published 
data [90] demonstrate that GC trigger EGFR activation by inducing the expression and 
surface cleavage of EGFR ligands using a transactivation mechanism. Furthermore, 
EGFR is recruited from the basolateral surface to GC adherent sites at the apical surface, 
an additional indication of loss of apical-basolateral polarity [90]. EGFR activation is 
known to activate β-catenin by inducing its phosphorylation and release from the 
junctional complex. This leads to the disassembly of the apical junction and frees 
epithelial cells from cell-cell contact inhibitory mechanisms required for cell proliferation 
and migration [166].  
 The results from this study provide novel evidence for a link between GC-induced 
junction disassembly and GC transmigration across polarized epithelial cells. Our results 
show a significant increase in GC transmigration when the apical junction is disrupted by 
EGTA and a decrease in GC transmigration when GC-induced β-catenin dissociation 
from the apical junction is inhibited by the EGFR kinase inhibitor. However, the exact 
signaling mechanism that facilitates GC transmigration across polarized genital epithelial 
cells remains to be further examined.  
 There are two possible mechanisms for GC transmigration, an intracellular 
mechanism where GC invade epithelial cells from the apical surface, transcytose through 
the cells and exit from the basolateral membrane, and a paracellular mechanism where 
GC migrate through the apical junction. The cell-cell junction localization of GC, the 
positive correlation of GC transmigration with the junction disassembly and regulation of 
transmigration, but not invasion, suggest a possible paracellular pathway for GC 




adherence and invasion as well. In polarized epithelial cells, the actin cytoskeleton is 
concentrated at the apical surface to support microvilli and the apical junction, thus 
strengthening the epithelial barrier. In contrast, some GC target molecules, such as CD46 
[15] and EGFR [90], are mainly expressed on the basolateral surface [87, 176]. GC-
induced reduction in the apical-basolateral polarity would allow these molecules to 
appear at the apical surface thus enhancing GC attachment and initiating signaling at the 
GC adherent sites. The disassociation of β-catenin from the apical junction can lead to 
detachment of the actin cytoskeleton from the apical junction and actin reorganization 
[52, 57, 149, 151], which can be utilized by GC for its invasion and transmigration. Since 
the EGFR kinase inhibitor does not completely block GC transmigration, it implies that 
there are additional mechanisms by which GC trigger transmigration.    
 Since EGFR is essential for the survival and polarization of epithelial cells, we 
were unable to use other approaches, such as si/shRNA knockdown, to confirm the 
results from the EGFR kinase inhibitor. Therefore, we utilized the approach of activating 
EGFR by addition of EGF. Our results show that EGF-induced EGFR activation 
increases GC transmigration, opposite of the effect of the EGFR kinase inhibitor that 
blocks EGFR activation and decreases GC transmigration, supporting the hypothesis that 
GC-induced EGFR transactivation is involved in GC transmigration. 
 Our results demonstrate that GC hijack the EGFR signaling pathway to breach the 
epithelial barrier for its transmigration. Further studies are required to define the cellular 
mechanisms by which GC transactivate EGFR and transmigrate across polarized 
epithelial cells. The resulting mechanistic knowledge will expand our understanding of 




Chapter 3: The Female Sex Hormones Estrogen and Progesterone 




Gonorrhea, a sexually transmitted infection (STI) caused by Neisseria gonorrhoeae, 
manifests differently in men and women. The infection in women is often asymptomatic, 
thus leaving the infection untreated and unattended. This increases the risk of the 
development of the infection into more serious disease sequelae, such as pelvic 
inflammatory disease (PID) a major cause of infertility. However, in men the disease 
readily induces an inflammatory response allowing diagnosis followed by treatment [3, 6, 
9, 177]. Due to anatomic differences of GC infection sites in men and women, the 
mechanisms used by GC to infect the male urethra versus the female reproductive tract 
may be different. In the male urethra, the bacteria establish an intimate interaction with 
the epithelial cells, inducing the secretion of cytokines and chemokines and the 
recruitment of leukocytes to the infection site. However, in infection of the lower female 
reproductive tract (FRT), GC interact with the epithelial cells causes membrane ruffling 
that facilitate bacterial internalization, but fails to elicit an immune response [13, 16, 29, 
177]. Even though this significant difference in GC pathogenesis has been known for 
years, the mechanism underlying this difference has not been elucidated.  
One of the major differences between the male urethra and female reproductive 
tracts is the female hormonal cycle that controls the menstrual cycle and prepares the 




FRT, and their respective receptors can be cytoplasmic, nuclear or plasma membrane 
bound [101]. Binding of the hormones to the receptor leads to receptor activation and 
translocation to the nucleus if the receptor is cytoplasmic. The active receptor complex 
then binds to the DNA and activates transcription. This process is considered the 
‘classical’ mechanism of hormone activation and requires 30-60 min to attain 
transcriptional activation. Hormone-receptor interaction can also induce fast (5-15 min) 
and transcriptional independent effects, which are considered ‘non-classical’ [101, 105, 
178]. The non-classical effects appear to be induced by receptors on the plasma 
membrane, which activate several cytoplasmic signaling cascades including mitogen 
activated protein kinases (MAPKs), phosphatidylinositol 3-kinase (PI3K) and protein 
kinase C (PKC) [178]. Recent studies have shown that the non-classical receptor 
pathways and epidermal growth factor receptor (EGFR) signaling pathways are 
intertwined and synergize each other [107, 178], and manipulate the regulation and 
shedding of the endometrium [111]. 
GC research involving hormones focuses on effects in broth culture [179, 180]. 
These experiments show that progesterone in the µg/ml range cause a concentration 
dependent decrease in GC growth. Where at 10 µg/ml, 70% of the control culture level 
remains after ~6 h incubation [179]. These levels are significantly higher than 
physiological peak progesterone serum levels of ~ 9 ng/ml [94] and of those used in this 
study (~15.7 ng/ml).  
Many STIs are affected by the presence of sex hormones. Brabin et al. [114] 
reported that the stage of the menstrual cycle and use of oral contraceptives influence 




Simplex Virus (HSV), human immunodeficiency virus (HIV) and gonorrhea. But the 
nature of the hormonal effects is dependent on the pathogen involved. The molecular and 
cellular mechanisms used by the hormones to either decrease or increase susceptibility 
are not fully elucidated. Using a mouse model of HSV, it has been shown that while 
estrogen has a protective effect against HSV, progesterone causes a significant increase 
in inflammation leading to death. Exposure to both estrogen and progesterone show 
increased protection against HSV. One mechanism proposed for the protective effect of 
estrogen is that estrogen induces thickening of the epithelial lining strengthening the 
epithelial barrier, but progesterone leads to thinning of the lining making it easier for the 
pathogen to cross the epithelium [181]. The hormones have a similar effect on Chlamydia 
infection, with the presence of estrogen abrogating the infection in mice while 
progesterone causes increased susceptibility [121]. Contrary to these results, inhibition of 
the estrogen receptor (ERα and ERβ) caused a significant decrease in the infectivity of 
chlamydia in the endometrial epithelial cells HEC-1-B [182].  
Similarly, clinical trials on the effects of contraceptive use on gonococcal 
infection generated inconsistent results. One study shows a protective effect of 
contraceptives [134] while others claim increased susceptibility [183-186], or no effect 
[132, 187-190]. Wu et al. examined the serum hormone levels of women with 
asymptomatic versus symptomatic GC infection and found a significantly higher level of 
progesterone in women with asymptomatic infection [133]. Replication of GC infection 
in the mouse model requires a long exposure to 17β-estradiol for a transient infection to 
occur [191]. The ability of this hormone to increase mouse susceptibility to GC infection 




inconsistent observations exemplify the lack of a comprehensive and mechanistic 
understanding of the relationship between the female hormonal cycle and GC 
pathogenicity. 
In this study we examine the effect of estrogen and progesterone on the various 
stages of GC pathogenesis in polarized cells. It is known that GC adhere to, invade into 
and transcytose across an epithelial layer facilitating pathogenesis [16, 17]. Most GC 
research has been performed on non-polarized cells, and the role of the female sex 
hormones in pathogenesis has not been examined. Our results show that while estrogen 
and progesterone have no effect on GC adherence and invasion into cells, they increase 
its transmigration across the monolayer. 
 
3.2. Materials and Methods 
3.2.1 Epithelial Cells 
Human endometrial adenocarcinoma cell line, HEC-1-B cells (ATCC# HTB-113, 
Manassas VA, USA), were maintained in Eagles MEM, alpha medium supplemented 
with 10% heat inactivated fetal bovine serum (FBS). Cells were maintained at 37°C and 
5% CO2. Cells were seeded at 6x104 (6.5 mm diameter transwell) per transwell (3 µm 
pore size, polyester transwell inserts, Corning, Lowell, MA, USA) and cultured for ~10 
days until transepithelial resistance (TER) reached ~400 Ω. TER was measured using a 







3.3.2 Neisseria Strains 
N. gonorrhoeae strain MS11 that expressed both pili and Opa (Pil+ Opa+) were used. 
Gonococci (GC) were grown on GC media base plates with 1% Kellogg’s supplement 
(GCK) [154] for 15–18 h before inoculation. Pil+ Opa+ colonies were acquired based on 
their morphology using a dissecting light microscope.  Bacteria were placed in 
suspension and the concentration determined using a spectrophotometer. GC were 
inoculated with epithelial cells at MOI 10:1.  
 
3.3.3 GC growth  
GC were grown in GC broth with Na2CO3 and Kellogs supplement added. After an initial 
reading of 5, hourly readings were taken for 8 h, using the Klett machine that determines 
concentration based on the optical density of the solution at 640nm. 
 
3.3.4 Immunofluorescence analysis 
Cells were pre-treated with or without estrogen [5nM or 50nM] (Sigma-Aldrich, St. 
Louis, MO, USA) or progesterone [5nM or 50nM] (Sigma-Aldrich, St. Louis, MO, USA) 
for 60 h, and incubated with GC in the presence or absence of GC at MOI 10. Cell were 
washed and fixed using a pH shift method [155], permeabilized, and stained with anti-
ZO-1 (BD Bioscience, Bedford, MA, USA) and anti-GC antibodies [156]. Cells were 
analyzed by confocal fluorescence microscopy (Zeiss LSM 510 or 710, Carl Zeiss 
Microscopy LLC, Thornwood, NY, USA). Z-series of images were obtained in 0.5 µm 
slices from the top to the bottom of cells, and three-dimensional (3D) composites 




showing discontinuous staining of junctional proteins was determined by visual 
inspection of multiple image slices.  
 
3.3.5 Functional analyses of the apical junction 
To determine the effect of GC on the gate function of polarized epithelial cells against the 
diffusion of molecules through the paracellular spaces, cells were incubated with GC and 
Lucifer yellow (50 µM, Sigma, Saint Louis, MO, USA) or FITC (50 µM, Acros 
Organics, Geel, Belgium) in the apical chamber for 6 h. The fluorescence intensity in the 
apical and basolateral media was then determined using a fluorometer.  
 
3.3.6 GC adherence, invasion and transmigration assays 
Polarized epithelia cells were untreated or pre-treated with ICI 182780 [5µM] (ER 
inhibitor) or mifipristone [5nµM] (PR inhibitor) and estrogen or progesterone, then 
incubated apically with GC for 3 h (adherence) or 6 h (invasion and transmigration) at  
37 °C. Cells were washed, lysed and plated on GCK after 3 h incubation to determine 
adherent CFU. Media from the basal compartment was collected and plated onto GCK to 
determine the number of transmigrated bacteria. Or after incubation cells were exposed to 
gentamicin (100 µg/ml) for 2 h, washed, lysed and plated to determine invaded bacteria. 
 
3.3 Results 
3.3.1 Sex Hormones do not affect GC growth  
The sex hormones, estrogen and progesterone, are a significant component of the 




cycle and control the shedding and regeneration of the epithelial lining of the FRT. Thus 
their role in GC infection in the reproductive system must be taken into account when 
trying to decipher mechanisms underlying GC pathogenesis. Previous work has shown 
that progesterone causes a decrease in GC growth in a time and concentration dependent 
manner [179, 180], but there was no analysis of the effect of 17β-estradiol on GC growth. 
To determine if either estrogen or progesterone affected GC growth, MS11 P+O+ GC 
collected from a 12 h GC plate were cultured in GC growth media in the absence of 
hormones or the presence of 17β-estradiol (50nM) or progesterone (50nM). Density 
readings were taken hourly and plotted (Fig. 17). These results show that the presence of 
neither 17β-estradiol nor progesterone causes any change in the growth pattern of GC at 
the concentration utilized for these experiments.  
 
3.3.2 Hormones slightly increase the localization of GC clusters at the cell-cell junction  
We have previously shown that live, but not gentamicin killed GC, preferentially 
localize at the cell-cell junction of polarized epithelial cells [Edwards 2012 submitted]. 
To investigate if sex hormones have any effect on GC localization, polarized HEC-1-B 
cells were pretreated apically and basally with estrogen or progesterone for 60 h then 
apically inoculated with GC at MOI 10 for 6 h in the absence or presence of hormones. 
Cells were fixed, permeabilized and stained for the ZO-1 and GC using specific 
antibodies, then analyzed using confocal microscopy. GC clusters at the cell-cell junction 
were visually identified and counted based on their spatial location to the junctional 
protein ZO-1 (Fig. 18A). The data shows that in the absence of hormones approximately  



























Figure 17. Sex hormones do not affect GC growth. 
MS11 P+O+ was grown in GC broth. GC at an initial 
Klett OD of 5 was added to the growth media and 




estrogen and progesterone GC at the cell-cell junction increased to 93% and 95%, 
respectively. These results indicate that hormones increase the localization of live GC 
clusters at the cell-cell junction.  
 
3.3.3 Hormones enhance GC induced redistribution of the junctional protein ZO-1. 
The increase in the percentage of cell-cell junctional localization of GC clusters 
indicates a possible role for hormones in facilitating GC-induced junction disassembly. 
To test this hypothesis, polarized HEC-1-B cells were pre-exposed to hormones then 
incubated with GC for 6 h in the continued presence of hormones. The apical junction 
was stained for ZO-1 and fluorescence confocal microscopy used to analyze the cellular 
distribution of ZO-1. In the absence of GC and hormones, ZO-1 staining appeared 
continuous along the cell membrane close to the apical surface (Fig. 18Ba), confirming 
polarization of HEC-1-B cells. Hormone treatment alone did not significantly change the 
distribution pattern of ZO-1 (Fig. 18B d, Bg). However, in the presence of GC, cells lost 
the continuous peripheral staining pattern of ZO-1, suggesting that there is disruption of 
the apical junction. We determined the percentage of epithelial cells with discontinuous 
ZO-1 staining as a quantitative measure for junctional disruption (Fig. 18B b,c,e,f,h,i). 
GC inoculation alone increases the percentage of epithelial cells with discontinuous 
staining from 16% to 74% (Fig. 18B). Hormone treatment with either 17β-estradiol or 
progesterone did not significantly increase this percentage. However, when comparing 
the distribution pattern, it was noted that ZO-1 staining in hormone treated and GC 
infected cells (Fig. 18Bd,e,h,i) appeared more disorganized than cells not exposed to 













































   
   
   
   
   
- 
a  b c 
d 




























Figure 18. Hormones slightly increase the localization of live GC at the cell-
cell junction, and enhance ZO-1 re-distribution in the presence of GC . 
Polarized HEC-1-B cells were unexposed (Ba-c) or pre exposed to estrogen (E) 
(Bd-f) or progesterone (P) (Bg-I) for 60 h and then apically inoculated with live 
GC (P+O+ MS11) (Bb,c, Be,f, Bh,I) at MOI 10 6 h. Cells were fixed, 
permeabilized and stained for ZO-1 and GC, and analyzed using confocal 
microscopy. The number of GC clusters localized at the cell-cell junction marked 
by ZO-1 was quantified by visual inspection (A). The number of host cells with 
disrupted peripheral ZO-1 staining was also visually analyzed and the average 
percentages (±S.D.) from three independent experiments were reported (C). Scale 




increase the number of epithelial cells with disrupted junctional complexes, they enhance 
the effect of junctional disruption.  
 
3.3.4 Permeability of the Junctional Complex is not affected by the presence of 
hormones 
Since junctional disruption was observed we needed to determine if the 
functionality of the junction was also affected by the presence of hormones in synergy 
with GC. Polarized HEC-1-B cells were unexposed or exposed to 17β-estradiol or 
progesterone and then apically inoculated with GC and Lucifer yellow dye (500 µM) for 
6 h. The basal and apical media were collected and the amount of Lucifer yellow was 
determined using a fluorometer. The Fluorescence Intensity Ratio (FIR) of Lucifer 
yellow in the basal to apical medium was calculated as an index of permeability. We did 
not detect any change in the permeability of the cells in the presence of 17β-estradiol or 
progesterone without (data not shown) or with GC inoculation (Fig. 19). These data 
suggest that while GC and hormones have a synergistic effect on the redistribution of the 
junctional protein ZO-1, they do not increase the permeability of the epithelium.  
 
3.3.5 Treatment with hormones increases GC transmigration without affecting GC 
adherence and invasion  
To determine whether the hormonal cycle of the FRT has any impact on GC 
infection, we examined the effects of 17β-estradiol or progesterone treatment on CG 
adherence to, invasion into, and transmigration across polarized epithelial cells: all 






























Figure 19. Permeability of the junctional complex is not affected by the 
presence of hormones. Polarized HEC-1-B cells were unexposed to various 
concentration of estrogen (E) or progesterone (P) for 60 h and incubated with 
or without GC for 6 h in the presence of Lucifer yellow dye. The 
fluorescence intensity of Lucifer yellow in the apical and basal compartments 
was determined using a fluorometer. The basal compared to apical FIR of 
Lucifer yellow was determined. Shown are the averages values (±S.D.) from 




with 17β-estradiol or progesterone then apically inoculated with GC for 3 h in the 
continued presence of hormones. Cells were washed to remove non-adherent bacteria, 
lysed and plated to determine epithelial cell associated GC. We found that the presence of 
neither 17β-estradiol nor progesterone cause a change in the level of GC adherence 
compared to cells that were not treated with hormones (Fig. 20A). To determine the 
number of invaded GC, incubation was extended to 6 h. The extracellular bacteria were 
killed by incubation with gentamicin and gentamicin resistant GC were determined as 
invaded bacteria. The results show that neither a low (5nM) nor high (50nM) level of 
17β-estradiol or progesterone (Fig. 20B) causes any change in GC invasion.  
To determine the effect of hormones on GC transmigration, polarized HEC-1-B 
cells were exposed to hormones and apically inoculated with GC for 6 h in the presence 
of the hormone. The number of GC in the basal medium was determined as transmigrated 
GC. Both 17β-estradiol (Fig. 20C) and progesterone (Fig. 20D) at the 50 nM 
concentration caused an ~ 5 fold increase in GC transmigration over hormone free cells. 
There was no significant increase observed at the lower hormone concentration. EGTA 
treatment, which completely disrupts the apical junction, showed ~ 25 fold increase in 
GC transmigration compared to untreated epithelial cells (Fig. 20C, D).  
These results collectively show that the sex hormones estrogen and progesterone,  
which synergize with GC in disrupting the apical junction of polarized epithelial cells, 







































Figure 20. Transmigration, but not adherence or invasion is affected by 17β-
estradiol or progesterone. Polarized HEC-1-B cells were unexposed or pre exposed 
to estrogen (E) or progesterone (P) for 60 h and then apically inoculated with live 
GC (P+O+ MS11) at MOI 10 for 3 h or 6 h. After 3 h cells were lysed and adherent 
bacteria plated on GCK (A). After 6 h GC innoculation cells were exposed to 
gentamicin for 2 h then lysed to determine invaded bacteria (B) or the basal media 
plated to determine transmigrated CG (C,D). Shown are the average CFU (±S.D.) 




3.3.6 Inhibition of the classical hormone receptors does not reverse the effect of 17β-
estradiol nor progesterone on GC transmigration  
To investigate if the hormones increase GC transmigration by activation of their 
receptors, we inhibited these receptors with classical receptor inhibitors ICI 182780 (17β-
estradiol) or mifipristone (progesterone). ICI 182780, is a pure antiestrogen that 
completely blocks the activity of the ER by binding to the ER and causing increased 
degradation and reduced dimerization of the receptor [103]. When mifepristone binds to 
the PR, it interacts with amino acids within the binding region and this induces a 
conformational change within the ligand binding domain that prevents interaction of PR 
with its cellular targets [104]. The classical receptor inhibitors inhibit the cytoplasmic and 
nuclear hormone receptors, but are less effective on the subset of receptors that reside on 
the plasma membrane and interact with GPCR and EGFR [178, 193]. There are no 
effective inhibitors available that directly inhibit the non-classical hormone receptors. To 
investigate if the inhibition of the classical receptors would block the effect of the 
hormones on GC transmigration, polarized HEC-1-B cells were pre-incubated with ICI 
182780 or mifipristone at 5 µM for 90 h before GC inoculation. At 60 h before 
inoculation, cells untreated or treated with inhibitors were incubated with 17β-estradiol or 
progesterone. Cells were apically inoculated with GC for 6 h, and transmigrated bacteria 
in the basal media were enumerated. The data show no significant difference in GC 
transmigration between cells that were treated with or without the hormone receptor 
inhibitor (Fig. 21). This result suggests that the classical hormone receptors may not be 
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Figure 21. Neither 17β-estradiol nor progesterone effects on transmigration 
are reversed by the presence of classical hormone receptor inhibitors. 
Polarized HEC-1-B cells were unexposed to hormones or pre treated with the 
receptor inhibitors to estrogen (ICI) or progesterone (Mif) for 90h and/or exposed 
to estrogen or progesterone for 60 h then exposed to GC for 6 h. Some cells were 
apically and basally exposed to EGTA [5nM] for 10 min then washed and exposed 
to GC for 6 h. Basal media was collected and plated to determine transmigrated 
GC. Shown are the average CFU (±S.D.) from two independent experiments. 




3.3.7 Inhibition of EGFR in the presence of 17β-estradiol or progesterone affects GC 
transmigration  
 Since the classical hormone receptor pathway does not appear to be involved in 
GC transmigration, we decided to determine if the non-classical pathway might be 
involved. There are exclusive inhibitors to the non-classical pathway, but since there 
appears to be crosstalk between the receptors and EGFR [105,173], we decided to inhibit 
EGFR kinase activity in the presence of the hormones and determine if this affected GC 
transmigration. Polarized HEC-1-B cells were incubated with 17β-estradiol or 
progesterone for 60 h. Cells were then exposed to AG1478 [10nM] for 2 h pre then 
apically inoculated with GC for 6 h, and transmigrated bacteria in the basal media were 
enumerated.  
 The results show that while the presence of the hormones increase GC 
transmigration, addition of the EGFR kinase inhibitor reduces transmigration under all 
conditions to a similar level (Fig. 22). Thus essentially transmigration in the presence of 
the hormones and AG1478 is reduced by a greater degree. This suggests that EGFR may 
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Figure 22. Inhibition of EGFR kinase activity reduces GC transmigration in 
the presence of both 17β-estradiol and progesterone. Polarized HEC-1-B cells 
were unexposed or treated with hormones for 60 h, then some cells were exposed 
to AG1478 for 2 h before inoculation with GC for 6 h. Basal media was collected 
and transmigrated bacteria plated on GCK plates. Shown are the CFU (±S.D.) 





The female sex hormones 17β-estradiol and progesterone play a significant role in 
determining the environment of the female reproductive tract (FRT). During the 
menstrual cycle estradiol levels peak at day 12 (~0.2 ng/ml) and progesterone peaks at 
day 23 (9 ng/ml). As the hormones fluctuate during the various stages of the menstrual 
cycle, they modulate the FRT and local immunity to accommodate reproductive changes 
and prepare for pregnancy [194, 195]. This study shows that physiological levels of both 
of these hormones enhance GC-induced disruption of the apical junction complex and 
cause an increase in GC transmigration. This suggests that the rise in estrogen and 
progesterone levels during the menstrual cycle potentially increase the susceptibility of 
women to GC infection and provide GC with two time windows of opportunity.  
Previous studies by Fitzgerald and Morse showed an inhibitory effect of 
progesterone on GC growth when GC were cultured with the hormone [179, 180], 
however, the GC strains studied did not include the MS11 strain and the concentrations 
analyzed were much higher than physiological levels and over 600-fold greater that that 
being utilized for these experiments. We found that neither progesterone nor estrogen 
caused a change in GC growth. The concentrations of progesterone (15.7 ng/ml) and 
estrogen (13.6 ng/ml) used in my studies were approximately 2-fold and 17-fold higher 
than blood levels respectively. While the exact hormone concentrations at the FRT are 
not known, they are generally higher than blood levels since they are locally secreted.  
Our research has shown that viable GC not only localize to the apical junctional 
complex, but also cause disruption of numerous junctional proteins, leading to reduced 




increase localization of GC clusters at the apical junction but do not significantly change 
the redistribution of ZO-1 from the periphery of the polarized cells. Since we hypothesize 
that GC clusters localizing at the cell-cell junction assist in facilitating pathogenesis, this 
increased localization of clusters at the junction in the presence of hormones would imply 
increased GC transmigration when hormones are present.   
Many pathogens overcome our body’s first line of defense, the epithelium by 
disrupting the apical junction. These pathogens, which include Enterohemorrhagic E. 
coli, Salmonella and Helicobacter pylori, destroy the junction thereby increasing the 
permeability of epithelial monolayers [46, 91, 160, 161, 168, 169]. Some pathogens such 
as Toxiplasma gondii can paracellularly cross the monolayer without destroying the 
apical junction [91], a phenomenon that GC might also be capable of performing. The 
other Neisseria pathogen, meningitidis, disrupts both occludin based tight junctions and 
VE-cadherin-based intercellular junctions of endothelial cells, providing a mechanism for 
crossing the brain blood barrier [92, 93, 170]. Studies in epithelial cells show that the 
bacteria are capable of transmigrating across the polarized epithelia without disrupting 
the junctional complex [196, 197]. If the junction is not destroyed but only transiently 
disrupted, permeability to small molecules might not be observed. Since the GC clusters 
localize on the junction they might fill the space thus preventing the molecules from 
going through, or might interact with the junction as they themselves paracellularly cross. 
Either mechanism would prevent small molecules, such as dyes from freely moving from 
the apical to basal compartment as observed with the Lucifer yellow dye.  
Adherence and invasion, two early stages of pathogenesis, were not affected by 




transmigration observed in a concentration dependent matter within the physiological 
range. Estrogen at 5nM and 50nM caused approximately a 5 and 10-fold increase 
respectively, over the no hormone control. At 5nM progesterone did not cause an 
increase over the no hormone control, but there was a 5 fold increase in the presence of 
50nM of progesterone. One mechanism of GC transcytosis could be the intracellular 
pathway, in which GC are apical endocytosed, traverse to the basolateral membrane and 
are exocytosed from the basal surface. Thus an increase in transcytosis should be 
concomitant with an increase in invasion. The fact that we observed no invasion increase, 
but a transmigration increase suggests that GC might be utilizing the paracellular 
pathway. This mechanism allows for the passage of GC between cells from the apical to 
basal compartment. The increased degree of junctional disruption in the presence of the 
hormones strengthens this possibility. Additionally, chemical destruction of the 
junctional complex by EGTA had no effect on GC invasion but facilitated a significant 
increase in transmigration, further reinforcing the paracellular pathway as a potential 
mechanism for GC transmigration.  
This study finds that the increase in GC transmigration by hormone treatment was 
not blocked by inhibition of the classical hormone receptors. While the efficacy of the 
inhibitors on hormone receptors needs to be confirmed, this result suggests that the 
mechanism involved in this transmigration event may not be mediated via the classical 
hormone activation pathway. This finding indicates a dependency of GC transmigration 
on the activation or activity of non-classical hormone receptors. Plasma membrane 
localized, non-classical receptors are believed to be more associated with signaling events 




Since these receptors also cross talk with EGFR, activation of these receptors by GC may 
explain the phenomenon observed. Inhibition of EGFR in the presence of the hormones 
caused a decrease in GC transmigration that was greater than the decrease observed when 
hormones were not present.  
The mechanism utilized for hormone-induced increase in transmigration is 
unknown. Either the hormones are activating the plasma bound receptors involved in 
non-classical hormone activation [101, 105, 178, 193] or GC itself might be interacting 
with these hormone receptors. Non-classical hormone receptors activate a number of 
signaling cascades [101] and synergize with EGFR signaling. Our previous studies 
demonstrated that GC can induce the transactivation of EGFR in epithelial cells and that 
EGFR activation is required for invasion into non-polarized cells and transmigration 
across polarized cells [90]. These findings suggest that GC and the hormones might be 
working in synergy to activate the EGFR signaling pathway to disrupt the apical junction 
and facilitate GC transmigration. Further experiments would have to be performed to 
determine the cellular mechanism(s) utilized for GC transmigration.     
In summary, our findings suggest that 17-β estradiol and progesterone play a role 
in GC pathogenesis. However, these findings only open the door to understanding the 
role of these sex hormones in the progression of gonococcal infection. Such knowledge 
will provide new strategies for preventative and therapeutic measures for GC infections 







Chapter 4: Conclusions 
4.1 General Summary 
Gonorrhea is the second most commonly reported sexually transmitted infection, 
and is caused by the human obligate gram-negative bacterial pathogen, Neisseria 
gonorrhoeae (GC). While the infection is typically recognized and cleared by the 
immune system in males, the infection in females often remains asymptomatic and thus 
untreated. Because it remains untreated it can progress into more complicated forms, such 
as pelvic inflammatory disease (PID). PID can lead to scarring of the fallopian tubes and 
cause other serious complications within the female reproductive system including 
ectopic pregnancies and infertility [3, 6, 7]. In addition to these reproductive 
complications, it has been observed that GC infection correlates with increased HIV 
infectivity [135, 136]. To progress to these complicated forms, the pathogen crosses the 
protective epithelial monolayer of the female reproductive tract (FRT) and invades the 
underlying tissues. Invasion into the underlying tissues also allows for evasion of the 
immune system, since once the bacteria are within the epithelial cells they are not 
exposed to cells of the immune system [13, 16]. The monolayer consists of apical 
junctional complexes that tightly hold neighboring cells together and prevent paracellular 
movement between cells. The junction also ensures that proteins and lipids remain in 
their appropriate apical or basolateral membrane location, maintaining functional 
polarization of the two surfaces [28, 35, 47].  
Many bacterial and viral pathogens have developed mechanisms to disrupt the 
junctional complex to facilitate their infection. The majority of gonococcal research has 




epithelial cells impacts the apical junction and GC pathogenesis has not been well 
studied. Based on the data from GC infection generally in non-polarized epithelial cells in 
vitro, GC infection has been proposed to occur through the stages of attachment, 
adherence, invasion, intracellular survival and exocytosis. Attachment and adherence are 
the early stages of infection and occur within the first few hours following exposure, this 
is followed by invasion into the cell within 4-6 hours. The bacteria survive within 
vacuoles or directly in the cytoplasm and can be found exocytosed approximately 18-40 h 
after inoculation, dependent on the GC strain used. The surface molecules pili, opa and 
LOS are all considered necessary for infectivity and pathogenicity.  
 The goals of this study were two-fold, (1) to determine if the interaction of GC 
with polarized epithelial cells affect the apical junction and if EGFR, which is known to 
be transactivated by GC in non-polarized epithelial cells, is involved in this process, and 
(2) to determine if the female sex hormones, estrogen and progesterone, play any role in 
GC pathogenesis. I developed these two projects independent of each other in order to 
explore two important aspects of GC pathogenesis that have not previously been 
examined. My studies show that when GC interact with polarized epithelial cells they 
prefer to localize around the apical junction. The junctional location of GC is concurrent 
with disassociation of the TJ proteins ZO-1 and occludin from the junction. Their 
disassociation leads to the disruption of the TJ and the association of the TJ with the actin 
cytoskeleton. In addition to the TJ proteins, GC inoculation also induced the 
redistribution of an adherens junction protein, β-catenin from the plasma membrane to 
the cytoplasm. This disassembly of the apical junction reduces the ‘fence’ function of the 




location, but does not significantly affect its ‘gate’ function, which controls the 
movement of molecules via the paracellular space.  
My studies show that degradation of the junctional proteins is not the mechanism 
for GC-induced junction disruption, since GC inoculation does not change the cellular 
levels of these junctional proteins. Instead, GC inoculation induces the tyrosine (Tyr) 
phosphorylation of β-catenin, which is known to lead to its redistribution away from the 
cell-cell junction [45, 48, 52, 54, 56, 58]. The presence of GC also leads to increased 
EGFR phosphorylation, a phenomenon previously observed by Swanson et al [90] in 
non-polarized cells. Using the EGFR kinase inhibitor, AG1478, I demonstrate that the 
dissociation of β-catenin is dependent on EGFR kinase activity. My results further show 
that disrupting the apical junction by EGTA increases GC transmigration and blocking 
GC induced junctional disruption by EGFR inhibitors reduces GC transmigration. These 
data collectively demonstrate that GC induced transactivation of EGFR triggers the 
phosphorylation of β-catenin [79], which leads to the disassembly of the apical junction 
and facilitate GC transmigration. 
Previous transmigration analysis within the filed has shown transmigration to be 
observed approximately 24 h post inoculation [4, 33-35]. During the course of my project 
I have consistently observed transmigration at the 6 h time point. This difference may be 
the result of the GC strain used and/or the stage of the infection process that was 
analyzed. My experiments used the MS11 strain, while the previous experiments used the 
FA1090 strain. While both originated as clinical isolates, FA1090 lacks a portion of the 
GC genome that is found in all other pathogenic strains [198]. Transmigration may occur 




analyzed in my experiments as compared to other experiments may be analyzing different 
stages of the infection process and possibly different forms of transmigration. The 
observed disruption of the junctional complex proteins indicates that paracellular 
transmigration is a feasible process that has not previously been extensively analyzed 
within the GC field.      
 The second goal of this thesis examines the role that estrogen and progesterone 
play in GC pathogenesis. Female sex hormones control the tissue reorganization of the 
female reproductive tract through the menstrual cycle and present a major difference 
between GC infection sites in male and female [94, 96, 177]. However, the relationship 
between the hormones and GC pathogenesis in the FRT has not been well examined. The 
effect of oral contraceptives and by extension hormones on susceptibility to GC infection 
is controversial and inconclusive. This makes a detailed investigation into the role of 
estrogen and progesterone even more relevant.   
 My research shows that physiological levels of estrogen and progesterone have no 
effect on the growth of GC. While they do not affect the percentage of host cells with 
disrupted tight junctions, they increase the percentage of GC localized at the cell-cell 
junction and the extent of junctional disruption. Unfortunately, there is currently no 
efficient method to quantify the extent of junction disruption. Neither hormone causes an 
increase in junctional paracellular permeability in the absence or presence of GC, leaving 
the ‘fence’ function unchanged. While physiological relevant levels of estrogen or 
progesterone have no effect on GC adherence and invasion, they increase GC 
transmigration in a concentration dependent manner. However, the classical hormone 




enhanced GC transmigration, suggesting the hormones exert their effects via a non-
classic pathway(s). Inhibition of EGFR kinase activity causes a greater decrease in GC 
transmigration, than that observed in the absence of hormones. These results support the 
role of the non-classical hormone receptor pathway in GC transmigration, since this 
pathway has been shown to work in synergy with the EGFR pathway.  
Taken together these results provide new insights into GC pathogenesis in the 
FRT where the female sex hormones are present. Our data suggest that the hormones 
synergize with GC to induce junctional disruption, consequently enhancing GC 
transmigration. GC breach the apical junction via transactivation of EGFR. EGFR is not 
only transactivated by GC [90], but has also been shown to be activated by ‘non-
classical’ hormone signaling [101, 105, 107]. I postulate that there is a synergistic 
relationship between the hormones and GC in the activation of EGFR receptors, which 
leads to the enhanced junction disruption and the increase in GC transmigration. Our 
findings that inhibition of EGFR activity reduced, while EGF increased, transmigration 
advocates a role for EGFR in GC transmigration supporting this hypothesis. I propose a 
working model utilizing a synergistic functional interaction between GC and the 

































Figure 23. Working model of EGFR activation leading to increased GC 
transmigration and the proposed synergistic effect of hormones on this process. 
GC interact with host cells, transactivate EGFR leading to the phosphorylation of β-
catenin and its disassociation from the junction, thus reducing the fence function. 
More EGFRs become apically localized and GC transmigrates across the monolayer. 
The presence of hormones facilitates activation of EGFR by an unknown mechanism, 
so when GC associate with the cells the junctional complex is already weakened. This 
leads to increased transmigration of the bacteria across the monolayer.   
 EGF  
EGFR 
















Hormones interact with their receptors or other as yet unknown receptors, leading 
to activation of EGFR signaling cascades by a currently unknown mechanism(s). This 
hormone-mediated EGFR activation synergizes with GC-induced EGFR transactivation.  
EGFR activation causes phosphorylation of β-catenin and its disassociation from the 
apical junction. Disruption of the junctional complex causes a decrease in the fence 
function of the apical junction, which allows basolaterally located EGFR to laterally 
move to the apical surface, so GC have an increased number of receptors to transactivate. 
The disruption of the junctional complex is perpetuated and GC transmigration increased. 
In the absence of hormones GC is able to transactivate EGFR leading to junctional 
disruption and reduced fence function, but without activation of EGFR by the sex 
hormone receptors there is overall reduced EGFR signaling. The actual mechanism that 
leads from EGFR transactivation to β-catenin phosphorylation and junction disruption 
needs to be elucidated.   
 There are two other mechanisms that potentially contribute to this process. First, 
estrogen and progesterone interact with and activate host surface receptors other than 
EGFR, such as trimeric G-protein coupled receptors, and use activated signaling cascades 
to disrupt the apical junction and allow GC targeted host receptors to be available on the 
apical surface. Second, GC may directly or indirectly interact with the hormone receptors 
and activate them, facilitating the junction disruption and increasing GC transmigration. 







4.2 Future Directions 
 The results obtained from this study and the resultant implications with regards to 
gonococcal pathogenesis open a window into the mechanism(s) used to facilitate GC 
transmigration. Further studies are required to fully elucidate the pathway from EGFR to 
β-catenin phosphorylation as well as the actual mechanism involved in the hormone 
based increase in GC transmigration. 
 GC causes EGFR transactivation [90], but the resultant downstream pathway that 
leads to β-catenin phosphorylation is unknown. While Erk is believed to be involved in 
EGF induced phosphorylation of β-catenin [150] it is not known if this is the pathway 
activated by GC. Inhibition studies and the resultant effect on GC transmigration must be 
performed. Immediate EGFR targets including phospholipase C gamma (PLCγ), 
phosphatidylinositol 3 kinase (PI3K) and Ras as well as proteins further downstream such 
as protein kinase C (PKC), Akt and Erk can be analyzed. Knockdown siRNA studies 
and/or inhibitory chemicals or proteins can be used to perform these experiments.  
Phosphorylation of β-catenin at Tyr 654 is important for its binding to E-cadherin 
and thus its localization at the cell-cell junction [58]. This Tyr residue can be mutated to 
Phe and the effect on its redistribution to the cytoplasm and the resultant effect on GC 
transmigration can be observed.   
A functional AJ is required for the formation of the TJ, making the AJ a crucial 
component of the junctional complex. While I analyzed the effect of β-catenin 
phosphorylation on its localization and inferred the effect that this would have on the 
junction, a more detailed analysis confirming reduced junctional functionality should be 




proteins in the absence or presence of GC should be analyzed. Any role that EGFR plays 
in this process should also be elucidated.  
While my study shows that the presence of estrogen and progesterone leads to 
increased GC transmigration, the actual mechanism underlying this phenomenon has not 
been examined. In order to examine if a synergistic relationship exists between GC and 
the sex hormones, signaling cascades must be examined. We know that GC activate 
EGFR [90] and both estrogen and progesterone can activate Erk 1/2, downstream 
components of EGFR pathway [107]. Gentamicin killed GC can be used instead of viable 
GC to observe any changes in signaling. Combinations of killed GC with hormones or 
viable GC with inactive hormone homologs can be used to determine if there is any 
synergistic effect. Activation levels of the hormone receptors, EGFR and downstream 
components of EGFR signaling cascades can be analyzed.  
While I have proposed a working model, there are other mechanisms that can be 
occurring either individually or simultaneously. GC may be interacting with and 
activating the hormone receptors leading to host signaling that facilitates GC 
transmigration. To examine this, activation levels of the hormone receptors can be 
examined in the absence and presence of GC. Receptor activation can be inhibited and 
the effect on GC transmigration determined.  
The other possible mechanism involves the activation of host surface receptors, in 
addition to EGFR, by estrogen and progesterone. It has been shown that estrogen can 
cause activation of Erk 1/2 via EGFR activation [107] as well as Akt in an ER 
independent manner [199]. This shows that non hormone receptors can be activated by 




presence of hormones can be examined. Receptors with increased activity in the presence 
of hormones can undergo sequential inhibition of activity by either siRNA or inhibitory 
proteins and GC transmigration observed. Non-functional hormone homologs that can 
interact with, but not stimulate activation of, receptors can also be used and the effect on 






















A.1 Delta Opa 
In addition to my two major research projects I also worked with the MS11 ∆opa 
strain that has been recently created in our lab by LeVan et al [200]. Opacity protein 
(Opa) is one of the surface molecules on Neisseria gonorrhoeae involved in pathogenesis 
and it mediates both adherence to and invasion into host cells [18]. MS11 strain expresses 
11 distinct Opa proteins encoded by individual opa genes [201]. These proteins are 
capable of phase and antigenic variation at a high rate (~103) [202]. These variations 
mean that a single GC colony can express multiple opa proteins and to varying levels. 
Under a dissecting microscope the presence of opa proteins causes an opaque, golden 
speckled appearance, but different Opas have differing degrees and shades of opacity. 
Due to the high rate of variation an accurate analysis of the role of Opa in GC 
pathogenesis may not truly have been obtained, since visually Opa lacking colonies may 
have low levels of Opa proteins present. As such our lab has constructed a MS11 strain 
that has all 11 genes either turned off or deleted, making a true ∆opa variant that cannot 
express Opa. Using this ∆opa MS11 strain I have analyzed three of the main stages of GC 
pathogenesis in the HEC-1-B cell line.  
 
A.1.1 Lack of Opa affects GC invasion into both non-polarized and polarized epithelial 
cells 
 The role of Opa in GC adherence and invasion has been previously examined in 




























Adherence                                  Invasion A B 
Figure. 24. Lack of opa affects GC invasion into cells. Non-polarized and 
polarized HEC-1-B cells were exposed to wild type or ∆opa GC for 3 h or 6 h. At 
3 h the cells were washed, lysed and plated to enumerate associated GC (A). 6 h 
post inoculation cells were exposed for 2 h to gentamicin and then lysed to 
determine invaded bacteria (B). Shown are the average CFU (±S.D.) from three 





increased adherence and invasion [18, 203]. These results reinforced the clinical 
observations that the majority of GC recovered after infection express Opa. Even when 
volunteers were inoculated with phenotypically Opa- GC mainly Opa+ GC were 
recovered [204, 205]. Using the ∆opa variant of MS11 there was no change in adherence 
to either non-polarized or polarized epithelial cells (Fig. 24A). However, there was an 
increase in invasion in non-polarized cells, while polarized cells showed a decrease in 
invasion (Fig. 24B).  
 
A.1.2 GC transmigration was increased in the absence of Opa 
Observing the later stage of pathogenesis, transmigration, there was an increase in 
transmigration across the polarized epithelial monolayer by GC lacking Opa (Fig 25). 
There were approximately 10 fold more ∆opa bacteria that transmigrated compared to 
their Opa+ counterparts. The majority of gonococcal research has been performed in non-
polarized cells, and observations from these cells have been assumed to represent the  
infection process. As we perform experiments in polarized cells, our lab is observing that 
some phenomena assumed to be universal for GC pathogenesis are not observed when 
polarized cells are infected. In some cases the opposite effect is observed. The lack of 
Opa would reduce the strength of GC-GC interactions and might make it easier for 
individual GC to be endocytosed. The 6 h time point would not be enough to facilitate 
exocytosis, so the bacteria would be observed in increased numbers within the cell. The 
increased transmigration across polarized cells coupled with the observed increased 
invasion in non-polarized cells suggests a possible paracellular route for GC transcytosis. 



























Figure. 25. Increased GC transmigration in the absence of 
Opa. Polarized HEC-1-B cells were exposed to O+ or ∆opa GC 
for 6 h and the basal media collected and plated to determine 
transmigrated GC. Shown are the average CFU (±S.D.) from 






to pass between the weakened junctional complex. If the bacteria are crossing the 
monolayer via this means, then there are fewer bacteria available to invade the cells.  
 
A.1.3 Predominantly Opa negative bacteria were recovered after transmigration 
 Finally, for invasion the majority of GC recovered were of the same Opa 
phenotype as the inoculum (Fig. 26). However for transmigration mainly phenotypic 
Opa- GC were recovered from the basal compartment, regardless of whether Opa was 
present or absent in the inoculum (Fig. 26). EGTA was used as a control that destroyed 
the junctional complex so that some of the bacteria transmigrated via the paracellular 
route. EGTA treated cells were inoculated with Opa expressing GC and while most of the 
recovered GC lacked Opa, there was a significant amount of Opa expressing GC.  
These results suggest that the lack of Opa may make GC more invasive and might 
play a role in complicated forms of the infection. HEC-1-B cells do not express 
CEACAM, a known Opa receptor, so this fact must be taken into account when analyzing 

































Figure. 26. Opa negative bacteria recovered after GC transmigration. 
Polarized HEC-1-B cells were exposed to O+ (in the absence or presence of 
EGTA) or ∆opa GC for 6 h and the phenotype of invaded and transmigrated GC 
visually determined using a dissecting microscope. The % of Opa lacking bacteria 





A.2 Layman’s Summary 
Gonorrhea, caused by the bacteria Neisseria gonorrhoeae, is a common sexually 
transmitted infection (STI). A high percentage of women who are infected show no 
symptoms, thus leaving the infection untreated and increasing the likelihood of 
complications such as infertility. Recent observations of increased co-infection of 
gonorrhea with HIV make it a significant public health threat. In the present study, we 
show that live gonococci (GC) position themselves at the apical junction that keeps 
neighboring epithelial cells tightly linked. They cause junctional proteins (ZO-1, occludin 
and β-catenin) to disassociate from the apical junction, reducing the functional integrity 
of the junction. GC increase the activation of a common host surface receptor, epidermal 
growth factor receptor (EGFR), and the phosphorylation of β-catenin. If the kinase 
activity of EGFR is inhibited, not only does the disassociation of β-catenin from the 
junction reduce, but the number of bacteria that migrate across the protective epithelial 
layer also decreases. These results reveal for the first time that GC can weaken the 
protective epithelial layer via a host cell receptor, suggesting a new mechanism utilized 
by GC to cross the protective epithelial layer. The presence of the female sex hormones 
estrogen and progesterone, increase GC transmigration across the polarized monolayer. 
This increase does not appear to be mediated by ‘classical’ hormone receptor signaling, 







1. Sena A, Ronald A, Fox K, Cohen M: Sexually Transmitted and Urinary Tract 
Infections. In: Tropical Infectious Diseases: Principles, Pathogens and Practice. 
Edited by Guerrant R, Walker D, Weller P, Third edn. Edinburgh: Elsevier; 2011: 
1033-1045. 
2. Kaushic C: The role of the local microenvironment in regulating susceptibility 
and immune responses to sexually transmitted viruses in the female genital 
tract. J Reprod Immunol 2009, 83(1-2):168-172. 
3. Hook EW, Holmes KK: Gonococcal infections. Ann Intern Med 1985, 
102(2):229-243. 
4. Merz AJ, So M: Interactions of pathogenic neisseriae with epithelial cell 
membranes. Annu Rev Cell Dev Biol 2000, 16:423-457. 
5. Andreoli T, Carpenter C, Griggs R, Loscalzo J: Cecil Essentials of Medicine, 
Sixth edn. Edinburgh: Saunders; 2003. 
6. Services UDoHaH: Sexually Transmitted Disease Surveillance 2010. In. 
Atlanta: Centers of Disease Control and Prevention; 2011. 
7. Harkness AH: The pathology of gonorrhoea. Br J Vener Dis 1948, 24(4):137-
147. 
8. Timmerman MM, Shao JQ, Apicella MA: Ultrastructural analysis of the 
pathogenesis of Neisseria gonorrhoeae endometrial infection. Cell Microbiol 
2005, 7(5):627-636. 
9. Holmes KK, Counts GW, Beaty HN: Disseminated gonococcal infection. Ann 




10. Kampmeier RH: Introduction of sulfonamide therapy for gonorrhea. Sex 
Transm Dis 1983, 10(2):81-84. 
11. Martin JE, Lester A, Price EV, Schmale JD: Comparative study of gonococcal 
susceptibility to penicillin in the United States, 1955-1969. J Infect Dis 1970, 
122(5):459-461. 
12. Nasraty S: Infections of the female genital tract. Prim Care 2003, 30(1):193-
203, vii. 
13. McGee ZA, Johnson AP, Taylor-Robinson D: Pathogenic mechanisms of 
Neisseria gonorrhoeae: observations on damage to human fallopian tubes in 
organ culture by gonococci of colony type 1 or type 4. J Infect Dis 1981, 
143(3):413-422. 
14. Ilver D, Källström H, Normark S, Jonsson AB: Transcellular passage of 
Neisseria gonorrhoeae involves pilus phase variation. Infect Immun 1998, 
66(2):469-473. 
15. Källström H, Liszewski MK, Atkinson JP, Jonsson AB: Membrane cofactor 
protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. 
Mol Microbiol 1997, 25(4):639-647. 
16. McGee ZA, Stephens DS, Hoffman LH, Schlech WF, Horn RG: Mechanisms of 
mucosal invasion by pathogenic Neisseria. Rev Infect Dis 1983, 5 Suppl 
4:S708-714. 
17. Mosleh IM, Boxberger HJ, Sessler MJ, Meyer TF: Experimental infection of 




intracellular fate, exocytosis, and passage through a stratified epithelium. 
Infect Immun 1997, 65(8):3391-3398. 
18. Dehio C, Gray-Owen SD, Meyer TF: The role of neisserial Opa proteins in 
interactions with host cells. Trends Microbiol 1998, 6(12):489-495. 
19. van Putten JP, Paul SM: Binding of syndecan-like cell surface proteoglycan 
receptors is required for Neisseria gonorrhoeae entry into human mucosal 
cells. EMBO J 1995, 14(10):2144-2154. 
20. Chen T, Grunert F, Medina-Marino A, Gotschlich EC: Several 
carcinoembryonic antigens (CD66) serve as receptors for gonococcal opacity 
proteins. J Exp Med 1997, 185(9):1557-1564. 
21. Virji M, Makepeace K, Ferguson DJ, Watt SM: Carcinoembryonic antigens 
(CD66) on epithelial cells and neutrophils are receptors for Opa proteins of 
pathogenic neisseriae. Mol Microbiol 1996, 22(5):941-950. 
22. Virji M, Watt SM, Barker S, Makepeace K, Doyonnas R: The N-domain of the 
human CD66a adhesion molecule is a target for Opa proteins of Neisseria 
meningitidis and Neisseria gonorrhoeae. Mol Microbiol 1996, 22(5):929-939. 
23. Apicella MA, Ketterer M, Lee FK, Zhou D, Rice PA, Blake MS: The 
pathogenesis of gonococcal urethritis in men: confocal and immunoelectron 
microscopic analysis of urethral exudates from men infected with Neisseria 
gonorrhoeae. J Infect Dis 1996, 173(3):636-646. 
24. Harvey HA, Ketterer MR, Preston A, Lubaroff D, Williams R, Apicella MA: 
Ultrastructural analysis of primary human urethral epithelial cell cultures 




25. Harvey HA, Jennings MP, Campbell CA, Williams R, Apicella MA: Receptor-
mediated endocytosis of Neisseria gonorrhoeae into primary human urethral 
epithelial cells: the role of the asialoglycoprotein receptor. Mol Microbiol 
2001, 42(3):659-672. 
26. Quan DN, Cooper MD, Potter JL, Roberts MH, Cheng H, Jarvis GA: TREM-2 
binds to lipooligosaccharides of Neisseria gonorrhoeae and is expressed on 
reproductive tract epithelial cells. Mucosal Immunol 2008, 1(3):229-238. 
27. Song W, Ma L, Chen R, Stein DC: Role of lipooligosaccharide in Opa-
independent invasion of Neisseria gonorrhoeae into human epithelial cells. J 
Exp Med 2000, 191(6):949-960. 
28. Shaw JH, Falkow S: Model for invasion of human tissue culture cells by 
Neisseria gonorrhoeae. Infect Immun 1988, 56(6):1625-1632. 
29. Griffiss JM, Lammel CJ, Wang J, Dekker NP, Brooks GF: Neisseria 
gonorrhoeae coordinately uses Pili and Opa to activate HEC-1-B cell 
microvilli, which causes engulfment of the gonococci. Infect Immun 1999, 
67(7):3469-3480. 
30. Zhang P, Schwartz O, Pantelic M, Li G, Knazze Q, Nobile C, Radovich M, He J, 
Hong SC, Klena J et al: DC-SIGN (CD209) recognition of Neisseria 
gonorrhoeae is circumvented by lipooligosaccharide variation. J Leukoc Biol 
2006, 79(4):731-738. 
31. Patrone JB, Stein DC: Effect of gonococcal lipooligosaccharide variation on 




32. Balthazar JT, Gusa A, Martin LE, Choudhury B, Carlson R, Shafer WM: 
Lipooligosaccharide Structure is an Important Determinant in the Resistance 
of Neisseria Gonorrhoeae to Antimicrobial Agents of Innate Host Defense. 
Front Microbiol 2011, 2:30. 
33. Hopper S, Wilbur JS, Vasquez BL, Larson J, Clary S, Mehr IJ, Seifert HS, So M: 
Isolation of Neisseria gonorrhoeae mutants that show enhanced trafficking 
across polarized T84 epithelial monolayers. Infect Immun 2000, 68(2):896-905. 
34. Wang JA, Meyer TF, Rudel T: Cytoskeleton and motor proteins are required 
for the transcytosis of Neisseria gonorrhoeae through polarized epithelial 
cells. Int J Med Microbiol 2008, 298(3-4):209-221. 
35. Merz AJ, Rifenbery DB, Arvidson CG, So M: Traversal of a polarized 
epithelium by pathogenic Neisseriae: facilitation by type IV pili and 
maintenance of epithelial barrier function. Mol Med 1996, 2(6):745-754. 
36. Seifert HS: Questions about gonococcal pilus phase- and antigenic variation. 
Mol Microbiol 1996, 21(3):433-440. 
37. Stern A, Brown M, Nickel P, Meyer TF: Opacity genes in Neisseria 
gonorrhoeae: control of phase and antigenic variation. Cell 1986, 47(1):61-71. 
38. Schneider H, Hammack CA, Apicella MA, Griffiss JM: Instability of expression 
of lipooligosaccharides and their epitopes in Neisseria gonorrhoeae. Infect 
Immun 1988, 56(4):942-946. 
39. Kellogg DS, Peacock WL, Deacon WE, Brown L, PirkleI DI: Neisseria 
Gonorrhoeae. I. Virulence Genetically Linked To Clonal Variation. J 




40. Makino S, van Putten JP, Meyer TF: Phase variation of the opacity outer 
membrane protein controls invasion by Neisseria gonorrhoeae into human 
epithelial cells. EMBO J 1991, 10(6):1307-1315. 
41. Haas R, Meyer TF: The repertoire of silent pilus genes in Neisseria 
gonorrhoeae: evidence for gene conversion. Cell 1986, 44(1):107-115. 
42. Swanson J, Bergström S, Barrera O, Robbins K, Corwin D: Pilus- gonococcal 
variants. Evidence for multiple forms of piliation control. J Exp Med 1985, 
162(2):729-744. 
43. Haas R, Schwarz H, Meyer TF: Release of soluble pilin antigen coupled with 
gene conversion in Neisseria gonorrhoeae. Proc Natl Acad Sci U S A 1987, 
84(24):9079-9083. 
44. Yang QL, Gotschlich EC: Variation of gonococcal lipooligosaccharide 
structure is due to alterations in poly-G tracts in lgt genes encoding glycosyl 
transferases. J Exp Med 1996, 183(1):323-327. 
45. Mitic LL, Anderson JM: Molecular architecture of tight junctions. Annu Rev 
Physiol 1998, 60:121-142. 
46. Miyoshi J, Takai Y: Molecular perspective on tight-junction assembly and 
epithelial polarity. Adv Drug Deliv Rev 2005, 57(6):815-855. 
47. Powell DW: Barrier function of epithelia. Am J Physiol 1981, 241(4):G275-
288. 
48. van Meer G, Simons K: The function of tight junctions in maintaining 
differences in lipid composition between the apical and the basolateral cell 




49. Farquhar MG, Palade GE: Junctional complexes in various epithelia. J Cell 
Biol 1963, 17:375-412. 
50. Claude P: Morphological factors influencing transepithelial permeability: a 
model for the resistance of the zonula occludens. J Membr Biol 1978, 39(2-
3):219-232. 
51. Niessen CM, Gottardi CJ: Molecular components of the adherens junction. 
Biochim Biophys Acta 2008, 1778(3):562-571. 
52. Anderson JM, Van Itallie CM: Tight junctions and the molecular basis for 
regulation of paracellular permeability. Am J Physiol 1995, 269(4 Pt 1):G467-
475. 
53. McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsukita S, Rogers RA, 
Lynch RD, Schneeberger EE: Occludin is a functional component of the tight 
junction. J Cell Sci 1996, 109 ( Pt 9):2287-2298. 
54. Balda MS, Whitney JA, Flores C, González S, Cereijido M, Matter K: Functional 
dissociation of paracellular permeability and transepithelial electrical 
resistance and disruption of the apical-basolateral intramembrane diffusion 
barrier by expression of a mutant tight junction membrane protein. J Cell 
Biol 1996, 134(4):1031-1049. 
55. Feldman GJ, Mullin JM, Ryan MP: Occludin: structure, function and 
regulation. Adv Drug Deliv Rev 2005, 57(6):883-917. 
56. Aberle H, Schwartz H, Kemler R: Cadherin-catenin complex: protein 





57. Hartsock A, Nelson WJ: Adherens and tight junctions: structure, function and 
connections to the actin cytoskeleton. Biochim Biophys Acta 2008, 1778(3):660-
669. 
58. Roura S, Miravet S, Piedra J, García de Herreros A, Duñach M: Regulation of E-
cadherin/Catenin association by tyrosine phosphorylation. J Biol Chem 1999, 
274(51):36734-36740. 
59. Ando-Akatsuka Y, Yonemura S, Itoh M, Furuse M, Tsukita S: Differential 
behavior of E-cadherin and occludin in their colocalization with ZO-1 during 
the establishment of epithelial cell polarity. J Cell Physiol 1999, 179(2):115-
125. 
60. Yonemura S, Itoh M, Nagafuchi A, Tsukita S: Cell-to-cell adherens junction 
formation and actin filament organization: similarities and differences 
between non-polarized fibroblasts and polarized epithelial cells. J Cell Sci 
1995, 108 ( Pt 1):127-142. 
61. Huber AH, Weis WI: The structure of the beta-catenin/E-cadherin complex 
and the molecular basis of diverse ligand recognition by beta-catenin. Cell 
2001, 105(3):391-402. 
62. Tsukita S, Nagafuchi A, Yonemura S: Molecular linkage between cadherins 
and actin filaments in cell-cell adherens junctions. Curr Opin Cell Biol 1992, 
4(5):834-839. 
63. Balda MS, Garrett MD, Matter K: The ZO-1-associated Y-box factor ZONAB 





64. Staehelin LA: Further observations on the fine structure of freeze-cleaved 
tight junctions. J Cell Sci 1973, 13(3):763-786. 
65. Madara JL: Maintenance of the macromolecular barrier at cell extrusion sites 
in intestinal epithelium: physiological rearrangement of tight junctions. J 
Membr Biol 1990, 116(2):177-184. 
66. Miller JR, McClay DR: Characterization of the role of cadherin in regulating 
cell adhesion during sea urchin development. Dev Biol 1997, 192(2):323-339. 
67. Oda H, Tsukita S, Takeichi M: Dynamic behavior of the cadherin-based cell-
cell adhesion system during Drosophila gastrulation. Dev Biol 1998, 
203(2):435-450. 
68. Marzesco AM, Dunia I, Pandjaitan R, Recouvreur M, Dauzonne D, Benedetti EL, 
Louvard D, Zahraoui A: The small GTPase Rab13 regulates assembly of 
functional tight junctions in epithelial cells. Mol Biol Cell 2002, 13(6):1819-
1831. 
69. Lapierre LA, Tuma PL, Navarre J, Goldenring JR, Anderson JM: VAP-33 
localizes to both an intracellular vesicle population and with occludin at the 
tight junction. J Cell Sci 1999, 112 ( Pt 21):3723-3732. 
70. Grindstaff KK, Yeaman C, Anandasabapathy N, Hsu SC, Rodriguez-Boulan E, 
Scheller RH, Nelson WJ: Sec6/8 complex is recruited to cell-cell contacts and 
specifies transport vesicle delivery to the basal-lateral membrane in epithelial 




71. Ivanov AI, Nusrat A, Parkos CA: Endocytosis of the apical junctional complex: 
mechanisms and possible roles in regulation of epithelial barriers. Bioessays 
2005, 27(4):356-365. 
72. Le TL, Yap AS, Stow JL: Recycling of E-cadherin: a potential mechanism for 
regulating cadherin dynamics. J Cell Biol 1999, 146(1):219-232. 
73. Matsuda M, Kubo A, Furuse M, Tsukita S: A peculiar internalization of 
claudins, tight junction-specific adhesion molecules, during the intercellular 
movement of epithelial cells. J Cell Sci 2004, 117(Pt 7):1247-1257. 
74. Izumi G, Sakisaka T, Baba T, Tanaka S, Morimoto K, Takai Y: Endocytosis of 
E-cadherin regulated by Rac and Cdc42 small G proteins through IQGAP1 
and actin filaments. J Cell Biol 2004, 166(2):237-248. 
75. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, 
Nusrat A: Proinflammatory cytokines disrupt epithelial barrier function by 
apoptosis-independent mechanisms. J Immunol 2003, 171(11):6164-6172. 
76. Alexander JS, Jackson SA, Chaney E, Kevil CG, Haselton FR: The role of 
cadherin endocytosis in endothelial barrier regulation: involvement of 
protein kinase C and actin-cadherin interactions. Inflammation 1998, 
22(4):419-433. 
77. Chen ML, Pothoulakis C, LaMont JT: Protein kinase C signaling regulates ZO-
1 translocation and increased paracellular flux of T84 colonocytes exposed to 




78. Rothen-Rutishauser B, Riesen FK, Braun A, Günthert M, Wunderli-Allenspach 
H: Dynamics of tight and adherens junctions under EGTA treatment. J 
Membr Biol 2002, 188(2):151-162. 
79. Yasmeen A, Bismar TA, Al Moustafa AE: ErbB receptors and epithelial-
cadherin-catenin complex in human carcinomas. Future Oncol 2006, 2(6):765-
781. 
80. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW: 
Epidermal growth factor receptor: mechanisms of activation and signalling. 
Exp Cell Res 2003, 284(1):31-53. 
81. Lemmon MA: Ligand-induced ErbB receptor dimerization. Exp Cell Res 
2009, 315(4):638-648. 
82. Carpenter G, Ji Q: Phospholipase C-gamma as a signal-transducing element. 
Exp Cell Res 1999, 253(1):15-24. 
83. Laffargue M, Raynal P, Yart A, Peres C, Wetzker R, Roche S, Payrastre B, Chap 
H: An epidermal growth factor receptor/Gab1 signaling pathway is required 
for activation of phosphoinositide 3-kinase by lysophosphatidic acid. J Biol 
Chem 1999, 274(46):32835-32841. 
84. Krall JA, Beyer EM, MacBeath G: High- and low-affinity epidermal growth 
factor receptor-ligand interactions activate distinct signaling pathways. PLoS 
One 2011, 6(1):e15945. 
85. Hobert M, Carlin C: Cytoplasmic juxtamembrane domain of the human EGF 





86. Chen MC, Goliger J, Bunnett N, Soll AH: Apical and basolateral EGF 
receptors regulate gastric mucosal paracellular permeability. Am J Physiol 
Gastrointest Liver Physiol 2001, 280(2):G264-272. 
87. Kuwada SK, Lund KA, Li XF, Cliften P, Amsler K, Opresko LK, Wiley HS: 
Differential signaling and regulation of apical vs. basolateral EGFR in 
polarized epithelial cells. Am J Physiol 1998, 275(6 Pt 1):C1419-1428. 
88. Sorkin A: Internalization of the epidermal growth factor receptor: role in 
signalling. Biochem Soc Trans 2001, 29(Pt 4):480-484. 
89. Takahashi K, Suzuki K, Tsukatani Y: Induction of tyrosine phosphorylation 
and association of beta-catenin with EGF receptor upon tryptic digestion of 
quiescent cells at confluence. Oncogene 1997, 15(1):71-78. 
90. Swanson KV, Griffiss JM, Edwards VL, Stein DC, Song W: Neisseria 
gonorrhoeae-induced transactivation of EGFR enhances gonococcal 
invasion. Cell Microbiol 2011, 13(7):1078-1090. 
91. Sousa S, Lecuit M, Cossart P: Microbial strategies to target, cross or disrupt 
epithelia. Curr Opin Cell Biol 2005, 17(5):489-498. 
92. Coureuil M, Mikaty G, Miller F, Lécuyer H, Bernard C, Bourdoulous S, Duménil 
G, Mège RM, Weksler BB, Romero IA et al: Meningococcal type IV pili recruit 
the polarity complex to cross the brain endothelium. Science 2009, 
325(5936):83-87. 
93. Schubert-Unkmeir A, Konrad C, Slanina H, Czapek F, Hebling S, Frosch M: 




detachment from the matrix and cleavage of occludin: a role for MMP-8. 
PLoS Pathog 2010, 6(4):e1000874. 
94. Owen JA: Physiology of the menstrual cycle. Am J Clin Nutr 1975, 28(4):333-
338. 
95. Thorneycroft IH, Boyers SP: The human menstrual cycle: correlation of 
hormonal patterns and clinical signs and symptoms. Obstet Gynecol Annu 
1983, 12:199-225. 
96. Fahey JV, Schaefer TM, Wira CR: Sex hormone modulation of human uterine 
epithelial cell immune responses. Integr Comp Biol 2006, 46(6):1082-1087. 
97. Li X, Zhou L, Gorodeski GI: Estrogen regulates epithelial cell deformability 
by modulation of cortical actomyosin through phosphorylation of nonmuscle 
myosin heavy-chain II-B filaments. Endocrinology 2006, 147(11):5236-5248. 
98. Fu XD, Simoncini T: Extra-nuclear signaling of estrogen receptors. IUBMB 
Life 2008, 60(8):502-510. 
99. Gorodeski GI: Estrogen decrease in tight junctional resistance involves 
matrix-metalloproteinase-7-mediated remodeling of occludin. Endocrinology 
2007, 148(1):218-231. 
100. Ellmann S, Sticht H, Thiel F, Beckmann MW, Strick R, Strissel PL: Estrogen 
and progesterone receptors: from molecular structures to clinical targets. 
Cell Mol Life Sci 2009, 66(15):2405-2426. 
101. Cato AC, Nestl A, Mink S: Rapid actions of steroid receptors in cellular 




102. Edwards DP: Regulation of signal transduction pathways by estrogen and 
progesterone. Annu Rev Physiol 2005, 67:335-376. 
103. Howell A, Osborne CK, Morris C, Wakeling AE: ICI 182,780 (Faslodex): 
development of a novel, "pure" antiestrogen. Cancer 2000, 89(4):817-825. 
104. Cadepond F, Ulmann A, Baulieu EE: RU486 (mifepristone): mechanisms of 
action and clinical uses. Annu Rev Med 1997, 48:129-156. 
105. Simoncini T, Genazzani AR: Non-genomic actions of sex steroid hormones. 
Eur J Endocrinol 2003, 148(3):281-292. 
106. van Biesen T, Hawes BE, Luttrell DK, Krueger KM, Touhara K, Porfiri E, 
Sakaue M, Luttrell LM, Lefkowitz RJ: Receptor-tyrosine-kinase- and G beta 
gamma-mediated MAP kinase activation by a common signalling pathway. 
Nature 1995, 376(6543):781-784. 
107. Filardo EJ, Quinn JA, Bland KI, Frackelton AR: Estrogen-induced activation of 
Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, 
and occurs via trans-activation of the epidermal growth factor receptor 
through release of HB-EGF. Mol Endocrinol 2000, 14(10):1649-1660. 
108. Wira C, Kaushic C, Richardson J: Role of sex hormones and cytokines in 
regulating mucosal immune system in the female reproductive system. In: 
Mucosal Immunity. Edited by Ogra P, Mestecky J, Lamm M, Strober W, 
Bienenstock J, McGhee J, Second edn. San Diego: Academic Press; 1999. 
109. Jabbour HN, Kelly RW, Fraser HM, Critchley HO: Endocrine regulation of 




110. Chabbert Buffet N, Djakoure C, Maitre SC, Bouchard P: Regulation of the 
human menstrual cycle. Front Neuroendocrinol 1998, 19(3):151-186. 
111. Silberstein SD, Merriam GR: Physiology of the menstrual cycle. Cephalalgia 
2000, 20(3):148-154. 
112. Fujimoto J, Sakaguchi H, Hirose R, Tamaya T: Significance of sex steroids in 
roles of cadherin subfamily and its related proteins in the uterine 
endometrium and placenta. Horm Res 1998, 50 Suppl 2:30-36. 
113. Kaushic C, Ferreira VH, Kafka JK, Nazli A: HIV infection in the female genital 
tract: discrete influence of the local mucosal microenvironment. Am J Reprod 
Immunol 2010, 63(6):566-575. 
114. Brabin L: Interactions of the female hormonal environment, susceptibility to 
viral infections, and disease progression. AIDS Patient Care STDS 2002, 
16(5):211-221. 
115. Kaushic C, Roth KL, Anipindi V, Xiu F: Increased prevalence of sexually 
transmitted viral infections in women: the role of female sex hormones in 
regulating susceptibility and immune responses. J Reprod Immunol 2011, 
88(2):204-209. 
116. Mabey D: Epidemiology of STIs: worldwide. Medicine 2010, 38(5):216-219. 






118. Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, Lackner AA, Mahoney CJ, 
Miller CJ, Claypool LE, Ho DD et al: Progesterone implants enhance SIV 
vaginal transmission and early virus load. Nat Med 1996, 2(10):1084-1089. 
119. Smith SM, Baskin GB, Marx PA: Estrogen protects against vaginal 
transmission of simian immunodeficiency virus. J Infect Dis 2000, 182(3):708-
715. 
120. Ochiel DO, Fahey JV, Ghosh M, Haddad SN, Wira CR: Innate Immunity in the 
Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine 
Epithelial Cell Protection Against Pathogens. Curr Womens Health Rev 2008, 
4(2):102-117. 
121. Kaushic C, Zhou F, Murdin AD, Wira CR: Effects of estradiol and 
progesterone on susceptibility and early immune responses to Chlamydia 
trachomatis infection in the female reproductive tract. Infect Immun 2000, 
68(7):4207-4216. 
122. Gillgrass AE, Ashkar AA, Rosenthal KL, Kaushic C: Prolonged exposure to 
progesterone prevents induction of protective mucosal responses following 
intravaginal immunization with attenuated herpes simplex virus type 2. J 
Virol 2003, 77(18):9845-9851. 
123. Jerse AE, Wu H, Packiam M, Vonck RA, Begum AA, Garvin LE: Estradiol-
Treated Female Mice as Surrogate Hosts for Neisseria gonorrhoeae Genital 




124. Riggs M, Klebanoff M, Nansel T, Zhang J, Schwebke J, Andrews W: 
Longitudinal association between hormonal contraceptives and bacterial 
vaginosis in women of reproductive age. Sex Transm Dis 2007, 34(12):954-959. 
125. Brotman RM, Erbelding EJ, Jamshidi RM, Klebanoff MA, Zenilman JM, 
Ghanem KG: Findings associated with recurrence of bacterial vaginosis 
among adolescents attending sexually transmitted diseases clinics. J Pediatr 
Adolesc Gynecol 2007, 20(4):225-231. 
126. Lavreys L, Baeten JM, Martin HL, Overbaugh J, Mandaliya K, Ndinya-Achola J, 
Kreiss JK: Hormonal contraception and risk of HIV-1 acquisition: results of a 
10-year prospective study. AIDS 2004, 18(4):695-697. 
127. Stringer EM, Kaseba C, Levy J, Sinkala M, Goldenberg RL, Chi BH, Matongo I, 
Vermund SH, Mwanahamuntu M, Stringer JS: A randomized trial of the 
intrauterine contraceptive device vs hormonal contraception in women who 
are infected with the human immunodeficiency virus. Am J Obstet Gynecol 
2007, 197(2):144.e141-148. 
128. Morrison CS, Richardson BA, Mmiro F, Chipato T, Celentano DD, Luoto J, 
Mugerwa R, Padian N, Rugpao S, Brown JM et al: Hormonal contraception 
and the risk of HIV acquisition. AIDS 2007, 21(1):85-95. 
129. Morrison CS, Chen PL, Kwok C, Richardson BA, Chipato T, Mugerwa R, 
Byamugisha J, Padian N, Celentano DD, Salata RA: Hormonal contraception 





130. Prakash M, Kapembwa MS, Gotch F, Patterson S: Oral contraceptive use 
induces upregulation of the CCR5 chemokine receptor on CD4(+) T cells in 
the cervical epithelium of healthy women. J Reprod Immunol 2002, 54(1-
2):117-131. 
131. Mohllajee AP, Curtis KM, Martins SL, Peterson HB: Hormonal contraceptive 
use and risk of sexually transmitted infections: a systematic review. 
Contraception 2006, 73(2):154-165. 
132. Baeten JM, Nyange PM, Richardson BA, Lavreys L, Chohan B, Martin HL, 
Mandaliya K, Ndinya-Achola JO, Bwayo JJ, Kreiss JK: Hormonal 
contraception and risk of sexually transmitted disease acquisition: results 
from a prospective study. Am J Obstet Gynecol 2001, 185(2):380-385. 
133. Wu Z, Xu L, Tu Y, Chen R, Yu Y, Li J, Tan M, Chen H: The relationship 
between the symptoms of female gonococcal infections and serum 
progesterone level and the genotypes of Neisseria gonorrhoeae multi-antigen 
sequence type (NG-MAST) in Wuhan, China. Eur J Clin Microbiol Infect Dis 
2011, 30(1):113-116. 
134. Gursahaney PR, Meyn LA, Hillier SL, Sweet RL, Wiesenfeld HC: Combined 
hormonal contraception may be protective against Neisseria gonorrhoeae 
infection. Sex Transm Dis 2010, 37(6):356-360. 
135. Sheung A, Rebbapragada A, Shin LY, Dobson-Belaire W, Kimani J, Ngugi E, 
MacDonald KS, Bwayo JJ, Moses S, Gray-Owen S et al: Mucosal Neisseria 
gonorrhoeae coinfection during HIV acquisition is associated with enhanced 




136. Ghys PD, Fransen K, Diallo MO, Ettiègne-Traoré V, Coulibaly IM, Yeboué KM, 
Kalish ML, Maurice C, Whitaker JP, Greenberg AE et al: The associations 
between cervicovaginal HIV shedding, sexually transmitted diseases and 
immunosuppression in female sex workers in Abidjan, Côte d'Ivoire. AIDS 
1997, 11(12):F85-93. 
137. Stephens DS: Gonococcal and meningococcal pathogenesis as defined by 
human cell, cell culture, and organ culture assays. Clin Microbiol Rev 1989, 2 
Suppl:S104-111. 
138. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A: 
EGF receptor transactivation by G-protein-coupled receptors requires 
metalloproteinase cleavage of proHB-EGF. Nature 1999, 402(6764):884-888. 
139. Schäfer B, Marg B, Gschwind A, Ullrich A: Distinct ADAM metalloproteinases 
regulate G protein-coupled receptor-induced cell proliferation and survival. 
J Biol Chem 2004, 279(46):47929-47938. 
140. Ohtsu H, Dempsey PJ, Eguchi S: ADAMs as mediators of EGF receptor 
transactivation by G protein-coupled receptors. Am J Physiol Cell Physiol 
2006, 291(1):C1-10. 
141. Wang J, Gray-Owen SD, Knorre A, Meyer TF, Dehio C: Opa binding to cellular 
CD66 receptors mediates the transcellular traversal of Neisseria gonorrhoeae 
across polarized T84 epithelial cell monolayers. Mol Microbiol 1998, 
30(3):657-671. 





143. Draper DL, James JF, Brooks GF, Sweet RL: Comparison of virulence markers 
of peritoneal and fallopian tube isolates with endocervical Neisseria 
gonorrhoeae isolates from women with acute salpingitis. Infect Immun 1980, 
27(3):882-888. 
144. Koch S, Nusrat A: Dynamic regulation of epithelial cell fate and barrier 
function by intercellular junctions. Ann N Y Acad Sci 2009, 1165:220-227. 
145. Miyoshi J, Takai Y: Structural and functional associations of apical junctions 
with cytoskeleton. Biochim Biophys Acta 2008, 1778(3):670-691. 
146. O'Keefe EJ, Briggaman RA, Herman B: Calcium-induced assembly of adherens 
junctions in keratinocytes. J Cell Biol 1987, 105(2):807-817. 
147. Harris TJ, Tepass U: Adherens junctions: from molecules to morphogenesis. 
Nat Rev Mol Cell Biol 2010, 11(7):502-514. 
148. Volberg T, Zick Y, Dror R, Sabanay I, Gilon C, Levitzki A, Geiger B: The effect 
of tyrosine-specific protein phosphorylation on the assembly of adherens-
type junctions. EMBO J 1992, 11(5):1733-1742. 
149. Nelson WJ: Regulation of cell-cell adhesion by the cadherin-catenin complex. 
Biochem Soc Trans 2008, 36(Pt 2):149-155. 
150. Hoschuetzky H, Aberle H, Kemler R: Beta-catenin mediates the interaction of 
the cadherin-catenin complex with epidermal growth factor receptor. J Cell 
Biol 1994, 127(5):1375-1380. 
151. Rao RK, Basuroy S, Rao VU, Karnaky Jr KJ, Gupta A: Tyrosine 




catenin complexes from the cytoskeleton by oxidative stress. Biochem J 2002, 
368(Pt 2):471-481. 
152. Kowalczyk AP, Reynolds AB: Protecting your tail: regulation of cadherin 
degradation by p120-catenin. Curr Opin Cell Biol 2004, 16(5):522-527. 
153. Shen Y, Hirsch DS, Sasiela CA, Wu WJ: Cdc42 regulates E-cadherin 
ubiquitination and degradation through an epidermal growth factor receptor 
to Src-mediated pathway. J Biol Chem 2008, 283(8):5127-5137. 
154. White LA, Kellogg DS: Neisseria Gonorrhoeae Identification In Direct 
Smears By A Fluorescent Antibody-Counterstain Method. Appl Microbiol 
1965, 13:171-174. 
155. Berod A, Hartman BK, Pujol JF: Importance of fixation in 
immunohistochemistry: use of formaldehyde solutions at variable pH for the 
localization of tyrosine hydroxylase. J Histochem Cytochem 1981, 29(7):844-
850. 
156. Bish SE, Song W, Stein DC: Quantification of bacterial internalization by host 
cells using a beta-lactamase reporter strain: Neisseria gonorrhoeae invasion 
into cervical epithelial cells requires bacterial viability. Microbes Infect 2008, 
10(10-11):1182-1191. 
157. Finlay BB, Cossart P: Exploitation of mammalian host cell functions by 
bacterial pathogens. Science 1997, 276(5313):718-725. 
158. Gruenheid S, Finlay BB: Microbial pathogenesis and cytoskeletal function. 




159. Katz J, Sambandam V, Wu JH, Michalek SM, Balkovetz DF: Characterization 
of Porphyromonas gingivalis-induced degradation of epithelial cell junctional 
complexes. Infect Immun 2000, 68(3):1441-1449. 
160. Ohl ME, Miller SI: Salmonella: a model for bacterial pathogenesis. Annu Rev 
Med 2001, 52:259-274. 
161. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S: 
Disruption of the epithelial apical-junctional complex by Helicobacter pylori 
CagA. Science 2003, 300(5624):1430-1434. 
162. Soriani M, Santi I, Taddei A, Rappuoli R, Grandi G, Telford JL: Group B 
Streptococcus crosses human epithelial cells by a paracellular route. J Infect 
Dis 2006, 193(2):241-250. 
163. Attali C, Durmort C, Vernet T, Di Guilmi AM: The interaction of Streptococcus 
pneumoniae with plasmin mediates transmigration across endothelial and 
epithelial monolayers by intercellular junction cleavage. Infect Immun 2008, 
76(11):5350-5356. 
164. Moon HS, Choi EA, Park HY, Choi JY, Chung HW, Kim JI, Park WI: 
Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-
catenin, and epidermal growth factor receptor in cervical cancer cells. 
Gynecol Oncol 2001, 81(3):355-359. 
165. Yang S, Guo X, Debnath G, Mohandas N, An X: Protein 4.1R links E-
cadherin/beta-catenin complex to the cytoskeleton through its direct 
interaction with beta-catenin and modulates adherens junction integrity. 




166. Ji H, Wang J, Nika H, Hawke D, Keezer S, Ge Q, Fang B, Fang X, Fang D, 
Litchfield DW et al: EGF-induced ERK activation promotes CK2-mediated 
disassociation of alpha-Catenin from beta-Catenin and transactivation of 
beta-Catenin. Mol Cell 2009, 36(4):547-559. 
167. Ray RM, Vaidya RJ, Johnson LR: MEK/ERK regulates adherens junctions 
and migration through Rac1. Cell Motil Cytoskeleton 2007, 64(3):143-156. 
168. Simonovic I, Rosenberg J, Koutsouris A, Hecht G: Enteropathogenic 
Escherichia coli dephosphorylates and dissociates occludin from intestinal 
epithelial tight junctions. Cell Microbiol 2000, 2(4):305-315. 
169. Muza-Moons MM, Koutsouris A, Hecht G: Disruption of cell polarity by 
enteropathogenic Escherichia coli enables basolateral membrane proteins to 
migrate apically and to potentiate physiological consequences. Infect Immun 
2003, 71(12):7069-7078. 
170. Coureuil M, Join-Lambert O, Lécuyer H, Bourdoulous S, Marullo S, Nassif X: 
Mechanism of meningeal invasion by Neisseria meningitidis. Virulence 2012, 
3(2). 
171. Rodríguez-Tirado C, Maisey K, Rodríguez FE, Reyes-Cerpa S, Reyes-López FE, 
Imarai M: Neisseria gonorrhoeae induced disruption of cell junction 
complexes in epithelial cells of the human genital tract. Microbes Infect 2012, 
14(3):290-300. 
172. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, 




tight junction proteins and penetrate gut epithelial monolayers to sample 
bacteria. Nat Immunol 2001, 2(4):361-367. 
173. Guttman JA, Finlay BB: Tight junctions as targets of infectious agents. 
Biochim Biophys Acta 2009, 1788(4):832-841. 
174. Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, Saito Y, Lu H, 
Ohnishi N, Azuma T, Suzuki A et al: Helicobacter pylori CagA targets 
PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007, 
447(7142):330-333. 
175. Coureuil M, Lécuyer H, Scott MG, Boularan C, Enslen H, Soyer M, Mikaty G, 
Bourdoulous S, Nassif X, Marullo S: Meningococcus Hijacks a β2-
adrenoceptor/β-Arrestin pathway to cross brain microvasculature 
endothelium. Cell 2010, 143(7):1149-1160. 
176. Maisner A, Zimmer G, Liszewski MK, Lublin DM, Atkinson JP, Herrler G: 
Membrane cofactor protein (CD46) is a basolateral protein that is not 
endocytosed. Importance of the tetrapeptide FTSL at the carboxyl terminus. 
J Biol Chem 1997, 272(33):20793-20799. 
177. Edwards JL, Apicella MA: The molecular mechanisms used by Neisseria 
gonorrhoeae to initiate infection differ between men and women. Clin 
Microbiol Rev 2004, 17(4):965-981, table of contents. 
178. Hammes SR, Levin ER: Extranuclear steroid receptors: nature and actions. 
Endocr Rev 2007, 28(7):726-741. 
179. Morse SA, Fitzgerald TJ: Effect of progesterone on Neisseria gonorrhoeae. 




180. Fitzgerald TJ, Morse SA: Alteration of growth, infectivity, and viability of 
Neisseria gonorrhoeae by gonadal steroids. Can J Microbiol 1976, 22(2):286-
294. 
181. Gillgrass AE, Fernandez SA, Rosenthal KL, Kaushic C: Estradiol regulates 
susceptibility following primary exposure to genital herpes simplex virus 
type 2, while progesterone induces inflammation. J Virol 2005, 79(5):3107-
3116. 
182. Hall JV, Schell M, Dessus-Babus S, Moore CG, Whittimore JD, Sal M, Dill BD, 
Wyrick PB: The multifaceted role of oestrogen in enhancing Chlamydia 
trachomatis infection in polarized human endometrial epithelial cells. Cell 
Microbiol 2011, 13(8):1183-1199. 
183. Hart G: Factors associated with genital chlamydial and gonococcal infection 
in females. Genitourin Med 1992, 68(4):217-220. 
184. Keith L, Berer GS, Moss W: Cervical gonorrhea in women using different 
methods of contraception. J Am Vener Dis Assoc 1976, 3(1):17-19. 
185. Berger GS, Keith L, Moss W: Prevalence of gonorrhoea among women using 
various methods of contraception. Br J Vener Dis 1975, 51(5):307-309. 
186. Gertig DM, Kapiga SH, Shao JF, Hunter DJ: Risk factors for sexually 
transmitted diseases among women attending family planning clinics in Dar-
es-Salaam, Tanzania. Genitourin Med 1997, 73(1):39-43. 
187. Louv WC, Austin H, Perlman J, Alexander WJ: Oral contraceptive use and the 





188. Lavreys L, Chohan V, Overbaugh J, Hassan W, McClelland RS, Kreiss J, 
Mandaliya K, Ndinya-Achola J, Baeten JM: Hormonal contraception and risk 
of cervical infections among HIV-1-seropositive Kenyan women. AIDS 2004, 
18(16):2179-2184. 
189. Austin H, Louv WC, Alexander WJ: A case-control study of spermicides and 
gonorrhea. JAMA 1984, 251(21):2822-2824. 
190. Jick H, Hannan MT, Stergachis A, Heidrich F, Perera DR, Rothman KJ: Vaginal 
spermicides and gonorrhea. JAMA 1982, 248(13):1619-1621. 
191. Dalal SJ, Estep JS, Valentin-Bon IE, Jerse AE: Standardization of the Whitten 
Effect to induce susceptibility to Neisseria gonorrhoeae in female mice. 
Contemp Top Lab Anim Sci 2001, 40(2):13-17. 
192. Kita E, Takahashi S, Yasui K, Kashiba S: Effect of estrogen (17 beta-estradiol) 
on the susceptibility of mice to disseminated gonococcal infection. Infect 
Immun 1985, 49(1):238-243. 
193. Boonyaratanakornkit V, Edwards DP: Receptor mechanisms mediating non-
genomic actions of sex steroids. Semin Reprod Med 2007, 25(3):139-153. 
194. Wira CR, Fahey JV: A new strategy to understand how HIV infects women: 
identification of a window of vulnerability during the menstrual cycle. AIDS 
2008, 22(15):1909-1917. 
195. Fahey JV, Wright JA, Shen L, Smith JM, Ghosh M, Rossoll RM, Wira CR: 
Estradiol selectively regulates innate immune function by polarized human 




196. Pujol C, Eugène E, de Saint Martin L, Nassif X: Interaction of Neisseria 
meningitidis with a polarized monolayer of epithelial cells. Infect Immun 1997, 
65(11):4836-4842. 
197. Sutherland TC, Quattroni P, Exley RM, Tang CM: Transcellular passage of 
Neisseria meningitidis across a polarized respiratory epithelium. Infect 
Immun 2010, 78(9):3832-3847. 
198. Dillard JP, Seifert HS: A variable genetic island specific for Neisseria 
gonorrhoeae is involved in providing DNA for natural transformation and is 
found more often in disseminated infection isolates. Mol Microbiol 2001, 
41(1):263-277. 
199. Tsai EM, Wang SC, Lee JN, Hung MC: Akt activation by estrogen in estrogen 
receptor-negative breast cancer cells. Cancer Res 2001, 61(23):8390-8392. 
200. LeVan A, Zimmerman L, Mahle A, Swanson K, DeShong P, Park J, Edwards V, 
Song W, Stein D: Construction and characterization of a derivative of 
Neisseria gonorrhoeae strain MS11 devoid of opa genes. Submitted to Journal 
of Bacteriology 2012. 
201. Bhat KS, Gibbs CP, Barrera O, Morrison SG, Jähnig F, Stern A, Kupsch EM, 
Meyer TF, Swanson J: The opacity proteins of Neisseria gonorrhoeae strain 
MS11 are encoded by a family of 11 complete genes. Mol Microbiol 1991, 
5(8):1889-1901. 
202. Mayer LW: Rates in vitro changes of gonococcal colony opacity phenotypes. 




203. Weel JF, Hopman CT, van Putten JP: In situ expression and localization of 
Neisseria gonorrhoeae opacity proteins in infected epithelial cells: apparent 
role of Opa proteins in cellular invasion. J Exp Med 1991, 173(6):1395-1405. 
204. Swanson J, Barrera O, Sola J, Boslego J: Expression of outer membrane 
protein II by gonococci in experimental gonorrhea. J Exp Med 1988, 
168(6):2121-2129. 
205. Jerse AE, Cohen MS, Drown PM, Whicker LG, Isbey SF, Seifert HS, Cannon JG: 
Multiple gonococcal opacity proteins are expressed during experimental 
urethral infection in the male. J Exp Med 1994, 179(3):911-920. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
